[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 574
1. Estrada Trigueros G, Comeche L, López Encuentra A, Montoro Zulueta J, González Garrido F, Colina F: [Bronchogenic carcinoma 2000-2001: characteristics and overall survival]. Arch Bronconeumol; 2007 Nov;43(11):594-8
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Bronchogenic carcinoma 2000-2001: characteristics and overall survival].
  • [Transliterated title] Carcinoma broncogénico 2000-2001: características y supervivencia global.
  • OBJECTIVE: To describe the clinical characteristics and survival of patients diagnosed with bronchogenic carcinoma during the years 2000 and 2001 in a tertiary level hospital.
  • Of all the patients diagnosed with or treated for bronchogenic carcinoma in our hospital, only those from our health care area were selected.
  • Large cell carcinomas accounted for 29.4% of cases.
  • Of all the cases of bronchogenic carcinoma, 41.3% were diagnosed in stage IV.
  • Thirty percent of non-small cell carcinomas were classified as stage I, compared to 6% of small cell carcinomas (P< .001).
  • The overall 5-year survival rate was 13% (95% confidence interval [CI], 10%-16%), while survival was significantly lower in patients aged 68 years or older (95% CI, 3%-15%; P< .001) and in patients with small cell carcinoma (0%, P< .01).
  • CONCLUSIONS: Our recent experience (2000-2001) confirmed the advanced age of patients with bronchogenic carcinoma, the frequency of diagnosis in advanced stages of the disease (41% in stage IV), and the low overall 5-year survival rate (13%).
  • [MeSH-major] Carcinoma, Bronchogenic / epidemiology. Lung Neoplasms / epidemiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17983542.001).
  • [ISSN] 0300-2896
  • [Journal-full-title] Archivos de bronconeumología
  • [ISO-abbreviation] Arch. Bronconeumol.
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Spain
  •  go-up   go-down


2. Peñalver Cuesta JC, Jordá Aragón C, Escrivá Peiró J, Cerón Navarro J, Calvo Medina V, Padilla Alarcón J: [Lung transplantation: bronchogenic carcinoma in the native lung]. Arch Bronconeumol; 2007 Feb;43(2):126-8
MedlinePlus Health Information. consumer health - Lung Transplantation.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Lung transplantation: bronchogenic carcinoma in the native lung].
  • [Transliterated title] Trasplante pulmonar. Carcinoma broncogénico en pulmón nativo.
  • In lung transplantation, the presence of bronchogenic carcinoma in the native organ is uncommon, but doubtless affects patient survival, independently of the transplantation process itself.
  • We describe 2 cases in which a primary tumor was found in the explanted lung--1 case of adenocarcinoma in a patient with pulmonary emphysema and 1 case of bronchioloalveolar carcinoma in a patient with idiopathic pulmonary fibrosis.
  • Both patients died due to the recurrence of the neoplastic disease.
  • [MeSH-major] Adenocarcinoma / etiology. Carcinoma, Bronchogenic / etiology. Lung Neoplasms / etiology. Lung Transplantation / adverse effects

  • Genetic Alliance. consumer health - Transplantation.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17288900.001).
  • [ISSN] 0300-2896
  • [Journal-full-title] Archivos de bronconeumología
  • [ISO-abbreviation] Arch. Bronconeumol.
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


3. Goldner B, Milosević Z, Sadiković S, Stojanović M: [Clinical and radiological manifestations of paraneoplastic syndrome of bronchogenic carcinoma]. Srp Arh Celok Lek; 2005 May-Jun;133(5-6):248-53
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Clinical and radiological manifestations of paraneoplastic syndrome of bronchogenic carcinoma].
  • The objective of this study was to present some clinical and radiological manifestations of PNS in relation to bronchogenic carcinoma (BC) and to evaluate the usefulness of imaging findings in the diagnosis of asymptomatic BC.
  • In the study group of 204 patients (146 male and 58 female) with proven bronchogenic carcinoma, PNS was present in 18 (8.62%) patients.
  • The first one consisted of 13 (72.2%) patients with symptoms related to primary tumours while the second one consisted of 5 (27.7%) patients with symptoms, at initial appearance, indicative of disorders of other organs and systems.
  • The predominant disorder was Lambert-Eaton Syndrome, associated with small-cell carcinoma.
  • Endocrine manifestations included: inappropriate antidiuretic hormone production syndrome (small-cell carcinoma), a gonadotropin effect with gynaecomastia and testicular atrophy (planocellular carcinoma, small-cell carcinoma), a case of Cushing Syndrome (small-cell carcinoma), and hypercalcaemia, due to the production of the parathyroid hormone-related peptide, which was associated with planocellular carcinoma.
  • In the first group, PNS occurred late on in the illness, while in the second group, PNS preceded the diagnosis of BC.
  • Radiological manifestations of PNS in asymptomatic patients may serve as a useful screen for identifying primary BC.
  • In symptomatic patients, it may be an indicator of a higher likelihood of metastatic disease.
  • [MeSH-major] Carcinoma, Bronchogenic / complications. Lung Neoplasms / complications. Paraneoplastic Syndromes / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16392281.001).
  • [ISSN] 0370-8179
  • [Journal-full-title] Srpski arhiv za celokupno lekarstvo
  • [ISO-abbreviation] Srp Arh Celok Lek
  • [Language] srp
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Serbia and Montenegro
  •  go-up   go-down


Advertisement
4. Duque JL, Rami-Porta R, Almaraz A, Castanedo M, Freixinet J, Fernández de Rota A, López Encuentra A, Grupo Cooperativo del Carcinoma Broncogénico SEPAR: [Risk factors in bronchogenic carcinoma surgery]. Arch Bronconeumol; 2007 Mar;43(3):143-9
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Risk factors in bronchogenic carcinoma surgery].
  • [Transliterated title] Parámetros de riesgo en la cirugía del carcinoma broncogénico.
  • OBJECTIVE: To analyze the factors that determine the risk of morbidity and mortality associated with lung resection in patients with bronchogenic carcinoma.
  • PATIENTS AND METHODS: Prospective multicenter study conducted between October 1, 1993 and September 30, 1997 in the 19 hospitals that make up the Bronchogenic Carcinoma Cooperative Group.
  • During the study period, 2994 patients with bronchogenic carcinoma underwent surgery.
  • CONCLUSIONS: Surgical treatment of bronchogenic carcinoma in Spain is associated with high morbidity and mortality.
  • [MeSH-major] Carcinoma, Bronchogenic / surgery. Lung Neoplasms / surgery. Pneumonectomy / statistics & numerical data. Postoperative Complications / etiology

  • MedlinePlus Health Information. consumer health - After Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17386190.001).
  • [ISSN] 0300-2896
  • [Journal-full-title] Archivos de bronconeumología
  • [ISO-abbreviation] Arch. Bronconeumol.
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


5. Padilla J, Cerón J, Peñalver JC, Jordá C, Pastor E, de Aguiar K: [Bronchogenic carcinoma in patients undergoing solid organ transplant. The role of surgery]. Cir Esp; 2009 Aug;86(2):101-4
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Bronchogenic carcinoma in patients undergoing solid organ transplant. The role of surgery].
  • [Transliterated title] Carcinoma broncogénico en pacientes con trasplante de órgano sólido. Papel de la cirugía.
  • However, the incidence of bronchogenic carcinoma (BC) is controversial.
  • The objective of our study was to determine the incidence of BC in a large cohort of transplant patients and the role of surgery.
  • MATERIAL AND METHODS: Until December 2006, 3596 patients underwent solid organ transplant at our institution; 24 (0.7%) patients subsequently developed BC, of which 6 (24%) were classified as clinical stage I and submitted to surgical treatment.
  • Two patients had cough, one accompanied by bloody expectoration, and BC was an incidental finding in the remaining cases.
  • The interval between transplant and diagnosis of BC was 38.1 months.
  • Epidermoid carcinoma was the most frequent histological type.
  • In subsequent follow-up, one patient died from BC metastasis, one from sepsis, one from chronic renal failure, and three remained alive.
  • CONCLUSIONS: The incidence of BC in patients undergoing solid organ transplant and the proportion of patients diagnosed in early stages does not differ from non-transplant patients diagnosed with BC, which questions the role of immunosuppression in the genesis and aggressiveness of BC in transplant patients.
  • [MeSH-major] Carcinoma, Bronchogenic / epidemiology. Heart Transplantation. Kidney Transplantation. Liver Transplantation. Lung Neoplasms / epidemiology


6. Call S, Rami-Porta R, Serra-Mitjans M, Saumench R, Bidegain C, Iglesias M, Gonzalez-Pont G, Belda J: Extended cervical mediastinoscopy in the staging of bronchogenic carcinoma of the left lung. Eur J Cardiothorac Surg; 2008 Nov;34(5):1081-4
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extended cervical mediastinoscopy in the staging of bronchogenic carcinoma of the left lung.
  • OBJECTIVE: To evaluate the technical feasibility and the sensitivity, specificity and accuracy of extended cervical mediastinoscopy (ECM) in the staging of bronchogenic carcinoma (BC) of the left lung.
  • METHODS: From 1998 to 2003, 89 patients underwent routine ECM for staging of BC of the left lung.
  • CONCLUSION: ECM is a feasible staging technique that allows ruling out subaortic and para-aortic nodal disease with high negative predictive value, accuracy and sensitivity.
  • Its indication based on the CT and PET findings seems more advisable that its routine use to stage bronchogenic carcinoma of the left lung.
  • [MeSH-major] Carcinoma, Bronchogenic / pathology. Lung Neoplasms / pathology. Mediastinoscopy / methods
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Feasibility Studies. Female. Humans. Lymph Node Excision. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Staging / methods. Positron-Emission Tomography. Sensitivity and Specificity. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Eur J Cardiothorac Surg. 2009 Apr;35(4):745; author reply 745 [19261486.001]
  • (PMID = 18760928.001).
  • [ISSN] 1873-734X
  • [Journal-full-title] European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
  • [ISO-abbreviation] Eur J Cardiothorac Surg
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


7. Shrestha HG, Chokhani R, Dhakhwa R: Clinicopathologic profile of bronchogenic carcinoma. JNMA J Nepal Med Assoc; 2010 Apr-Jun;49(178):100-3
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinicopathologic profile of bronchogenic carcinoma.
  • INTRODUCTION: Bronchogenic carcinoma is the most common cancer in the world.
  • Accurate diagnosis and categorization into different types is important because of its effect on prognosis and management.
  • We conducted this study to find out the frequency of various histological types of bronchogenic carcinoma and correlate with their clinicopathologic profile.
  • METHODS: This is a retrospective study conducted in 174 histopathologically proven cases of bronchogenic carcinoma that were referred from different parts of the country to a private hospital in Kathmandu over a period of 4 years.
  • RESULTS: The mean age of the patients developing bronchogenic carcinoma was 64 years.
  • Squamous cell carcinoma was the commonest histologic subtype followed by small cell carcinoma.
  • CONCLUSIONS: The lung cancer must be ruled out in all patients who have persistent signs and symptoms of pulmonary disease with a history of smoking.
  • [MeSH-major] Carcinoma / pathology. Lung Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21485592.001).
  • [ISSN] 0028-2715
  • [Journal-full-title] JNMA; journal of the Nepal Medical Association
  • [ISO-abbreviation] JNMA J Nepal Med Assoc
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Nepal
  •  go-up   go-down


8. Cañizares Carretero MA, Rivo Vázquez JE, Blanco Ramos M, Toscano Novella A, García Fontán EM, Purriños Hermida MJ: [Influence of delay of surgery on the survival of patients with bronchogenic carcinoma]. Arch Bronconeumol; 2007 Mar;43(3):165-70
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Influence of delay of surgery on the survival of patients with bronchogenic carcinoma].
  • [Transliterated title] Influencia de la demora quirúrgica en la supervivencia de los pacientes intervenidos por carcinoma broncogénico.
  • OBJECTIVE: Bronchogenic carcinoma is the main cause of tumor-related deaths among men in Spain.
  • We analyzed the influence of time until surgery on survival in patients with lung cancer.
  • PATIENTS AND METHODS: We operated on 108 patients diagnosed with bronchogenic carcinoma between January 1, 2001 and December 31, 2002.
  • CONCLUSIONS: We found no evidence that delaying surgery affects survival in lung cancer patients.
  • [MeSH-major] Carcinoma, Bronchogenic / surgery. Lung Neoplasms / surgery. Pneumonectomy / statistics & numerical data. Waiting Lists
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Cohort Studies. Female. Humans. Kaplan-Meier Estimate. Male. Middle Aged. Neoplasm Staging / statistics & numerical data. Prognosis. Thoracotomy / statistics & numerical data. Time Factors

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17386194.001).
  • [ISSN] 0300-2896
  • [Journal-full-title] Archivos de bronconeumología
  • [ISO-abbreviation] Arch. Bronconeumol.
  • [Language] spa
  • [Publication-type] Comparative Study; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


9. Woznick AR, Braddock AL, Dulai M, Seymour ML, Callahan RE, Welsh RJ, Chmielewski GW, Zelenock GB, Shanley CJ: Lysyl oxidase expression in bronchogenic carcinoma. Am J Surg; 2005 Mar;189(3):297-301
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lysyl oxidase expression in bronchogenic carcinoma.
  • Recent studies have documented differential lysyl oxidase expression in the stromal reaction to colon, breast, prostate, and lung cancer.
  • The present study was undertaken to test the hypothesis that lysyl oxidase mRNA and protein expression decrease with advancing tumor stage in patients with bronchogenic carcinoma.
  • METHODS: Tumor specimens were obtained from 17 patients undergoing resection for bronchogenic carcinoma.
  • CONCLUSIONS: These results support the hypothesis that variations in lysyl oxidase expression may correlate with the invasive and metastatic potential of bronchogenic carcinoma.
  • [MeSH-major] Adenocarcinoma / enzymology. Carcinoma, Bronchogenic / enzymology. Lung Neoplasms / enzymology. Protein-Lysine 6-Oxidase / metabolism
  • [MeSH-minor] Humans. Lung / enzymology. Lung / pathology. Neoplasm Staging. RNA, Messenger / metabolism. Reverse Transcriptase Polymerase Chain Reaction

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15792754.001).
  • [ISSN] 0002-9610
  • [Journal-full-title] American journal of surgery
  • [ISO-abbreviation] Am. J. Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RNA, Messenger; EC 1.4.3.13 / Protein-Lysine 6-Oxidase
  •  go-up   go-down


10. El Ouazzani H, Menchafou I, Achachi L, El Ftouh M, El Fassy Fihry MT: [Delay in the diagnosis of primary bronchial cancer. Study carried out in the pneumology unit of Ibn Sina university hospital, Rabat (Morocco)]. Rev Pneumol Clin; 2010 Dec;66(6):335-41
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Delay in the diagnosis of primary bronchial cancer. Study carried out in the pneumology unit of Ibn Sina university hospital, Rabat (Morocco)].
  • [Transliterated title] Retard diagnostique du cancer bronchique primitif. Étude réalisée dans le service de pneumologie du CHU Ibn Sina de Rabat (Maroc).
  • INTRODUCTION: Primary bronchial cancer (PBC) is a major public health problem.
  • The diagnosis is often late resulting in a poor prognosis.
  • PURPOSE: To determine the factors leading to a late diagnosis.
  • The date of the first symptom (D1s), the date of care (Dpch), the date of the diagnosis (Ddg) and the date of the beginning of treatment (Dttt) were used to determine the delay before care.
  • The medium delay before hospitalisation (D1s to Dpch) was 76 days, the delay before the diagnosis (Dpch to Ddg) was 25 days, the time before treatment (Ddg to Dttt) was 27 days, the time between hospitalisation and treatment (Dpch to Dttt) was 69 days, the overall delay (D1s to Dttt) was 160 days.
  • The time before the diagnosis was longer in cases with a low socioeconomic level (30 days vs. 21 days, p: 0.06).
  • The time before treatment was shorter for small cell carcinomas (SCC) (23 days vs. 31 days: p: 0.06).
  • CONCLUSION: The study confirms the problem of a delay in diagnosis.
  • [MeSH-major] Carcinoma, Bronchogenic / diagnosis. Developing Countries. Lung Neoplasms / diagnosis
  • [MeSH-minor] Adenocarcinoma / diagnosis. Adenocarcinoma / epidemiology. Adenocarcinoma / pathology. Adenocarcinoma / therapy. Adult. Aged. Aged, 80 and over. Carcinoma, Large Cell / diagnosis. Carcinoma, Large Cell / epidemiology. Carcinoma, Large Cell / pathology. Carcinoma, Large Cell / therapy. Carcinoma, Squamous Cell / diagnosis. Carcinoma, Squamous Cell / epidemiology. Carcinoma, Squamous Cell / pathology. Carcinoma, Squamous Cell / therapy. Female. Health Services Accessibility / statistics & numerical data. Hospitals, University. Humans. Male. Middle Aged. Morocco. Neoplasm Staging. Patient Admission / statistics & numerical data. Smoking / adverse effects. Smoking / pathology. Socioeconomic Factors. Uncompensated Care / statistics & numerical data

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Masson SAS. All rights reserved.
  • (PMID = 21167440.001).
  • [ISSN] 0761-8417
  • [Journal-full-title] Revue de pneumologie clinique
  • [ISO-abbreviation] Rev Pneumol Clin
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


11. Gonzalez HA Sr: Pleurodesis with systemic chemotherapy in cancer patients. J Clin Oncol; 2009 May 20;27(15_suppl):e20688

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pleurodesis with systemic chemotherapy in cancer patients.
  • : e20688 Background: Pleural effusions are a common complication in cancer.
  • Diagnosis is clinical and paraclinical.
  • In cancer patients, in pneumonia absence, most of pleural effusions are malignant, regardless cytology results.
  • The objective of this study was measure systemic chemotherapy effectiveness in cancer pleural effusion after drainage and emphasize this method as treatment.
  • METHODS: Beginning 1/March/2001 and finalizing 30/July/2006, patients with chemosensitive cancers, malignant pleural effusions, no previous chemotherapy, KI > 80, life expectancy > 6 months, were included.
  • Cancers: bronchogenic carcinoma: 42,8%, breast carcinoma: 28,5%, ovarian carcinoma: 14,2 %, carcinoma of unknown origin: 9,52%, others: 4,76%.
  • Clinical stages: III B: 57,2%, most of them bronchogenic carcinoma, IV: 42,8%.
  • CONCLUSIONS: Systemic chemotherapy after draining effusions is a good approach for treating chemosensitive cancer pleural effusions, because can produce pleurodesis, is etiologic, has a high effectiveness and can improve survival.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961784.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


12. Xu G, Lai G, Liu D, Lin Q: [Study on the value of cytopathology in diagnosis of primary bronchogenic carcinoma of the lung]. Zhongguo Fei Ai Za Zhi; 2006 Dec 20;9(6):544-6

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Study on the value of cytopathology in diagnosis of primary bronchogenic carcinoma of the lung].
  • BACKGROUND: Pathology is the "gold standard" of the diagnosis of lung cancer, but at present there are few articles about evaluating the value of cytopathological check.
  • The aim of this study is to evaluate the value of cytopathological check in the diagnosis of primary bronchogenic carcinoma of the lung.
  • The samples included pleural fluids (110 for 68 patients), materials from lung puncture (33 for 31 patients), smears of transcatheter bronchial brushing (152 for 138 patients), bronchoalveolar lavage fluids (30 for 26 patients) and sputa (227 for 118 patients).
  • RESULTS: The positive results of different specimens were as follow: the pleural fluids was 69.12%, the materials from lung puncture 67.74%, the smears of transcatheter bronchial brushing 65.22%, the bronchoalveolar lavage fluids 23.08% and sputa 21.19% respectively.
  • The positive rates of the pleural fluids, the materials from lung puncture and the smears of transcatheter bronchial brushing were higher than that of the bronchoalveolar lavage fluids and sputa (P < 0.01).
  • There was no significant difference among the positive rates of the pleural fluids, the materials from lung puncture and the smears of transcatheter bronchial brushing, and between the positive rates of the bronchoalveolar lavage fluids and sputa (P > 0.05).
  • CONCLUSIONS: The cytopathological examination is helpful for the diagnosis of primary bronchogenic carcinoma of the lung, and is one of the important ways to the diagnosis of primary bronchogenic carcinoma of the lung.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21182819.001).
  • [ISSN] 1009-3419
  • [Journal-full-title] Zhongguo fei ai za zhi = Chinese journal of lung cancer
  • [ISO-abbreviation] Zhongguo Fei Ai Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


13. Camargo Jde J, Machuca TN, Camargo SM, Schio SM, Bello RM: Synchronous pulmonary and hepatic nodules in a patient with previous bronchogenic carcinoma: the relevance of histopathological confirmation. J Bras Pneumol; 2009 Jun;35(6):602-5
MedlinePlus Health Information. consumer health - Lung Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Synchronous pulmonary and hepatic nodules in a patient with previous bronchogenic carcinoma: the relevance of histopathological confirmation.
  • The synchronous presentation of pulmonary and hepatic nodules in a patient with previously resected bronchogenic carcinoma raises suspicion of recurrence and mandates restaging.
  • Despite the strong suspicion of tumor recurrence, further investigation with a percutaneous liver biopsy revealed hepatocellular carcinoma.
  • In order to investigate the etiology of the pulmonary lesion (hypotheses of recurrent bronchial cancer and of metastatic hepatocellular carcinoma), an open lung biopsy was performed, which revealed chronic inflammatory tissue with foci of anthracosis and dystrophic calcification.
  • This report highlights the relevance of the histopathological diagnosis in patients with a history of bronchogenic carcinoma and suspicion of tumor recurrence.
  • [MeSH-major] Calcinosis / complications. Carcinoma, Hepatocellular / complications. Liver Neoplasms / complications. Lung Diseases / complications
  • [MeSH-minor] Aged. Biopsy. Carcinoma, Bronchogenic / surgery. Humans. Lung Neoplasms / surgery. Male. Neoplasm Staging. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19618039.001).
  • [ISSN] 1806-3756
  • [Journal-full-title] Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia
  • [ISO-abbreviation] J Bras Pneumol
  • [Language] eng; por
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


14. Tzaveas A, Paraskevas G, Pazis I, Dimitriadis A, Kitsoulis P, Vrettakos A: Metastasis of bronchogenic carcinoma to the 5th metacarpal bone: a case report. Cases J; 2008;1(1):284

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastasis of bronchogenic carcinoma to the 5th metacarpal bone: a case report.
  • CASE PRESENTATION: We present a patient with metastasis of bronchogenic carcinoma of the lung to the 5th metacarpal to draw the attention for the potential of such lesions to be developed in this region.
  • CONCLUSION: The surgeon should be cautious regarding the differential diagnosis, the usual poor prognosis of such patients and the questionable need for reconstructive surgery.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Bone Joint Surg Br. 2007 Sep;89(9):1243-6 [17905966.001]
  • [Cites] Scand J Plast Reconstr Surg Hand Surg. 2005;39(2):113-5 [16019740.001]
  • [Cites] Cancer. 1997 Sep 15;80(6):1103-9 [9305711.001]
  • [Cites] Mod Pathol. 1991 Jan;4(1):66-9 [2020663.001]
  • [Cites] South Med J. 1999 Oct;92(10):1009-12 [10548176.001]
  • [Cites] Cancer. 1980 Feb 15;45(4):824-8 [7357500.001]
  • [Cites] Clin Orthop Relat Res. 1975 May;(108):182-6 [166784.001]
  • [Cites] J Hand Surg Am. 2002 Sep;27(5):876-81 [12239679.001]
  • [Cites] J Hand Surg Am. 2001 Jan;26(1):156-60 [11172383.001]
  • [Cites] Clin Orthop Relat Res. 1984 Sep;(188):230-3 [6467720.001]
  • (PMID = 18973651.001).
  • [ISSN] 1757-1626
  • [Journal-full-title] Cases journal
  • [ISO-abbreviation] Cases J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2590610
  •  go-up   go-down


15. Gómez Sebastián G, Güell Rous R, González Valencia A, Fibla Alfara JJ, Estrada Saló G, León González C: [Impact of a rescue program on the operability of patients with bronchogenic carcinoma and chronic obstructive pulmonary disease]. Arch Bronconeumol; 2007 May;43(5):262-6
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Impact of a rescue program on the operability of patients with bronchogenic carcinoma and chronic obstructive pulmonary disease].
  • [Transliterated title] Influencia de un programa de rescate en la decisión quirúrgica en pacientes con carcinoma broncogénico y EPOC.
  • OBJECTIVE: Bronchogenic carcinoma and chronic obstructive pulmonary disease (COPD) are strongly associated in our setting, occurring together in around 70% of cases.
  • Approximately 60% of COPD patients who require resection for bronchogenic carcinoma are considered unfit for surgery because of seriously impaired lung function.
  • The purpose of this study was to evaluate the extent to which a rescue program could improve lung function in COPD patients who had previously been considered unfit for surgery because of poor lung function.
  • Lung function was analyzed before and after the program.
  • Twenty-four patients (80%) showed significant improvement in lung function (P< .001) after the program and were admitted for resection.
  • CONCLUSIONS: A large number (80%) of COPD patients previously considered unfit for surgical resection because of seriously impaired lung function can be admitted for surgery following an intensive drug and respiratory physiotherapy rescue program.
  • [MeSH-major] Carcinoma, Bronchogenic / complications. Carcinoma, Bronchogenic / surgery. Lung Neoplasms / complications. Lung Neoplasms / surgery. Pulmonary Disease, Chronic Obstructive / complications


16. Prasad R, Verma SK, Sanjay: Comparison between young and old patients with bronchogenic carcinoma. J Cancer Res Ther; 2009 Jan-Mar;5(1):31-5
MedlinePlus Health Information. consumer health - Smoking.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparison between young and old patients with bronchogenic carcinoma.
  • OBJECTIVE: This study was undertaken to explore the clinicopathological profile of bronchogenic carcinoma in young patients.
  • MATERIALS AND METHODS: The present study was conducted on 799 consecutive histopathologically proven cases of bronchogenic carcinoma that were referred from different parts of Uttar Pradesh.
  • Squamous cell carcinoma was the commonest histological subtype in both the groups, but squamous cell carcinoma was more frequently diagnosed in older patients than in younger patients.
  • CONCLUSION: This study suggests that, regardless of age or sex, lung cancer must be ruled out in all patients who have persistent signs of pulmonary disease and a history of heavy smoking.
  • [MeSH-major] Carcinoma, Bronchogenic / pathology. Carcinoma, Bronchogenic / physiopathology. Lung Neoplasms / pathology. Lung Neoplasms / physiopathology. Smoking / adverse effects
  • [MeSH-minor] Adult. Carcinoma, Squamous Cell / etiology. Carcinoma, Squamous Cell / pathology. Carcinoma, Squamous Cell / physiopathology. Female. Humans. Male. Middle Aged. Neoplasm Staging

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19293486.001).
  • [ISSN] 1998-4138
  • [Journal-full-title] Journal of cancer research and therapeutics
  • [ISO-abbreviation] J Cancer Res Ther
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] India
  •  go-up   go-down


17. Maki D, Takahashi M, Murata K, Sawai S, Fujino S, Inoue S: Computed tomography appearances of bronchogenic carcinoma associated with bullous lung disease. J Comput Assist Tomogr; 2006 May-Jun;30(3):447-52
MedlinePlus Health Information. consumer health - Lung Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Computed tomography appearances of bronchogenic carcinoma associated with bullous lung disease.
  • Bullous lung disease is known to be a risk factor for developing a bronchogenic carcinoma.
  • In this article, computed tomography appearances of 20 patients with histologically proven bronchogenic carcinoma were reviewed retrospectively.
  • On the basis of the previous literatures and our findings, the computed tomography appearances of bronchogenic carcinoma associated with bullous lung disease could be classified into 3 types; nodule or mass extruding from the bullous wall, nodule or mass confined within the bullous lumen, and soft-tissue density extending along the bullous wall.
  • Attention should be paid in the interpretations for mass or nodule in the wall of the bulla because they frequently lack the characteristic appearances of bronchogenic carcinoma.
  • [MeSH-major] Carcinoma, Bronchogenic / complications. Carcinoma, Bronchogenic / radiography. Lung Diseases / complications. Lung Diseases / radiography. Lung Neoplasms / complications. Lung Neoplasms / radiography. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16778620.001).
  • [ISSN] 0363-8715
  • [Journal-full-title] Journal of computer assisted tomography
  • [ISO-abbreviation] J Comput Assist Tomogr
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


18. Takahashi M, Murakami Y, Nitta N, Murata K, Tezuka N, Fujino S, Okabe H: Pulmonary infarction associated with bronchogenic carcinoma. Radiat Med; 2008 Feb;26(2):76-80
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pulmonary infarction associated with bronchogenic carcinoma.
  • Computed tomography findings of pathologically proven pulmonary infarction associated with bronchogenic carcinoma are reported for two patients.
  • We conclude that pulmonary infarction should be considered as a differential diagnosis when peripheral pulmonary nodules or masses are located in the same lobe as the primary cancer.
  • [MeSH-major] Adenocarcinoma / diagnosis. Carcinoma, Bronchogenic / diagnosis. Carcinoma, Small Cell / diagnosis. Lung Neoplasms / diagnosis. Pulmonary Infarction / diagnosis
  • [MeSH-minor] Contrast Media / administration & dosage. Diagnosis, Differential. Humans. Incidental Findings. Lung / radiography. Lung / surgery. Male. Middle Aged. Radiographic Image Enhancement / methods. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18301982.001).
  • [ISSN] 0288-2043
  • [Journal-full-title] Radiation medicine
  • [ISO-abbreviation] Radiat Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Contrast Media
  •  go-up   go-down


19. Mullins DN, Crawford EL, Khuder SA, Hernandez DA, Yoon Y, Willey JC: CEBPG transcription factor correlates with antioxidant and DNA repair genes in normal bronchial epithelial cells but not in individuals with bronchogenic carcinoma. BMC Cancer; 2005 Oct 29;5:141
antibodies-online. View related products from antibodies-online.com (subscription/membership/fee required).

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] CEBPG transcription factor correlates with antioxidant and DNA repair genes in normal bronchial epithelial cells but not in individuals with bronchogenic carcinoma.
  • BACKGROUND: Cigarette smoking is the primary cause of bronchogenic carcinoma (BC), yet only 10-15% of heavy smokers develop BC and it is likely that this variation in risk is, in part, genetically determined.
  • We previously reported a set of antioxidant genes for which transcript abundance was lower in normal bronchial epithelial cells (NBEC) of BC individuals compared to non-BC individuals.
  • From these data, we hypothesized that antioxidant and DNA repair genes are co-regulated by one or more transcription factors and that inter-individual variation in expression and/or function of one or more of these transcription factors is responsible for inter-individual variation in risk for BC.
  • The transcript abundance values of these transcription factors (n = 6) and an expanded group of antioxidant and DNA repair genes (n = 16) were measured simultaneously by quantitative PCR in NBEC of 24 non-BC and 25 BC individuals.
  • RESULTS: CEBPG transcription factor was significantly (p < 0.01) correlated with eight of the antioxidant or DNA repair genes in non-BC individuals but not in BC individuals.
  • In BC individuals the correlation with CEBPG was significantly (p < 0.01) lower than that of non-BC individuals for four of the genes (XRCC1, ERCC5, GSTP1, and SOD1) and the difference was nearly significant for GPX1.
  • The only other transcription factor correlated with any of these five target genes in non-BC individuals was E2F1.
  • E2F1 was correlated with GSTP1 among non-BC individuals, but in contrast to CEBPG, there was no significant difference in this correlation in non-BC individuals compared to BC individuals.
  • CONCLUSION: We conclude that CEBPG is the transcription factor primarily responsible for regulating transcription of key antioxidant and DNA repair genes in non-BC individuals.
  • Further, we conclude that the heavy smokers selected for development of BC are those who have sub-optimal regulation of antioxidant and DNA repair genes by CEBPG.

  • MedlinePlus Health Information. consumer health - Antioxidants.
  • COS Scholar Universe. author profiles.
  • Gene Ontology. gene/protein/disease-specific - Gene Ontology annotations from this paper .
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Exp Med. 1999 Dec 6;190(11):1573-82 [10587348.001]
  • [Cites] Oncogene. 2005 Apr 7;24(15):2449-60 [15735727.001]
  • [Cites] Int J Oncol. 2000 Aug;17(2):375-80 [10891549.001]
  • [Cites] Genes Dev. 2002 Jan 15;16(2):245-56 [11799067.001]
  • [Cites] Biochem Biophys Res Commun. 2002 Apr 26;293(1):509-16 [12054630.001]
  • [Cites] J Biol Chem. 2002 Oct 11;277(41):38827-37 [12177065.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1544-9 [12496041.001]
  • [Cites] Clin J Oncol Nurs. 2003 Nov-Dec;7(6):699-702 [14705493.001]
  • [Cites] Methods Mol Biol. 2004;258:13-41 [14970455.001]
  • [Cites] Genomics. 2004 Jun;83(6):970-9 [15177551.001]
  • [Cites] Lab Invest. 1982 Nov;47(5):412-26 [6290784.001]
  • [Cites] Blood. 1992 Jun 15;79(12):3233-8 [1339300.001]
  • [Cites] Environ Health Perspect. 1992 Nov;98:87-94 [1486868.001]
  • [Cites] Cancer Res. 1993 Dec 1;53(23):5643-8 [8242618.001]
  • [Cites] Trends Biochem Sci. 1995 Oct;20(10):391-7 [8533150.001]
  • [Cites] Nucleic Acids Res. 1995 Nov 11;23(21):4371-7 [7501458.001]
  • [Cites] Nucleic Acids Res. 1995 Dec 11;23(23):4878-84 [8532532.001]
  • [Cites] Am J Respir Cell Mol Biol. 1996 Mar;14(3):262-71 [8845177.001]
  • [Cites] Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):341-57 [9279209.001]
  • [Cites] Cancer Res. 2000 Mar 15;60(6):1609-18 [10749130.001]
  • (PMID = 16255782.001).
  • [ISSN] 1471-2407
  • [Journal-full-title] BMC cancer
  • [ISO-abbreviation] BMC Cancer
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R24 CA095806; United States / NCI NIH HHS / CA / U01 CA085147; United States / NCI NIH HHS / CA / CA 95806; United States / NCI NIH HHS / CA / CA85147
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antioxidants; 0 / CCAAT-Enhancer-Binding Proteins; 0 / CCAAT-enhancer-binding protein-gamma; 0 / DNA excision repair protein ERCC-5; 0 / DNA-Binding Proteins; 0 / Nuclear Proteins; 0 / Transcription Factors; 0 / X-ray repair cross complementing protein 1; EC 1.11.1.- / glutathione peroxidase GPX1; EC 1.11.1.9 / Glutathione Peroxidase; EC 1.15.1.- / superoxide dismutase 1; EC 1.15.1.1 / Superoxide Dismutase; EC 2.5.1.18 / GSTP1 protein, human; EC 2.5.1.18 / Glutathione S-Transferase pi; EC 3.1.- / Endonucleases
  • [Other-IDs] NLM/ PMC1310620
  •  go-up   go-down


20. Pant P, Sedhain A, D'Souza S, Renuka BG: Unusual site of metastasis of bronchogenic carcinoma. Kathmandu Univ Med J (KUMJ); 2010 Oct-Dec;8(32):420-2
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unusual site of metastasis of bronchogenic carcinoma.
  • Metastasis of bronchogenic carcinoma to the chest wall and axillary lymphnodes is a rare occurrence.
  • Here, we discuss the pathways and possible mechanisms of contra lateral axillary and chest wall lymphnode involvement without ispilateral nodal involvement in bronchogenic carcinoma.
  • [MeSH-major] Carcinoma, Bronchogenic / secondary. Lung Neoplasms / pathology. Lymph Nodes / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22610773.001).
  • [ISSN] 1812-2078
  • [Journal-full-title] Kathmandu University medical journal (KUMJ)
  • [ISO-abbreviation] Kathmandu Univ Med J (KUMJ)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Nepal
  •  go-up   go-down


21. Cheng JH, Huang YC, Kuo C, Lai YS, Wu TC, Tsao TC, Luh SP, Tsai CB: Double primary bronchogenic carcinoma of the lung and papillary thyroid carcinoma: a case report. J Med Case Rep; 2008;2:309

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Double primary bronchogenic carcinoma of the lung and papillary thyroid carcinoma: a case report.
  • INTRODUCTION: Double primary bronchogenic carcinoma and papillary carcinoma of the thyroid are extremely rare.
  • A slowly growing mass in the left lobe of the lung had been noted for about 1 year.
  • A left thyroid lobectomy was performed and pathology revealed a papillary carcinoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Gan No Rinsho. 1983 Oct;29(12):1385-91 [6645058.001]
  • [Cites] J Thorac Cardiovasc Surg. 2004 Apr;127(4):1119-25 [15052211.001]
  • [Cites] Lung Cancer. 2002 Feb;35(2):189-94 [11804692.001]
  • [Cites] Kyobu Geka. 2000 Feb;53(2):101-5 [10667017.001]
  • [Cites] Cancer Lett. 2008 May 8;263(1):44-52 [18226854.001]
  • [Cites] Am J Epidemiol. 2007 Nov 15;166(10):1140-9 [17855390.001]
  • [Cites] Nihon Kyobu Geka Gakkai Zasshi. 1989 Jun;37(6):1233-7 [2681446.001]
  • [Cites] Jpn J Clin Oncol. 1997 Apr;27(2):63-6 [9152791.001]
  • [Cites] Surg Today. 1999;29(7):670-4 [10452251.001]
  • [Cites] J Nucl Med. 1998 Sep;39(9):1531-6 [9744337.001]
  • [Cites] Zhonghua Zhong Liu Za Zhi. 1996 Jul;18(4):296-8 [9387326.001]
  • [Cites] Head Neck. 1994 Sep-Oct;16(5):438-42 [7960741.001]
  • [Cites] Acta Morphol Hung. 1992;40(1-4):95-102 [1365776.001]
  • [Cites] Ai Zheng. 2006 Jun;25(6):731-5 [16764770.001]
  • (PMID = 18811948.001).
  • [ISSN] 1752-1947
  • [Journal-full-title] Journal of medical case reports
  • [ISO-abbreviation] J Med Case Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2557019
  •  go-up   go-down


22. Jacob S, Mohapatra D, Verghese M: Massive chondroid hamartoma of the lung clinically masquerading as bronchogenic carcinoma. Indian J Pathol Microbiol; 2008 Jan-Mar;51(1):61-2
MedlinePlus Health Information. consumer health - Lung Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Massive chondroid hamartoma of the lung clinically masquerading as bronchogenic carcinoma.
  • Chondroid hamartomas of the lung are uncommon lesions which are generally small sized and asymptomatic.
  • Herein we describe a case of a large-sized pulmonary chondroid hamartoma which clinically mimicked bronchogenic carcinoma.
  • A large hilar growth was detected in the left lung on radiological studies.
  • [MeSH-major] Hamartoma / diagnosis. Lung Diseases / pathology
  • [MeSH-minor] Carcinoma, Bronchogenic / diagnosis. Diagnosis, Differential. Female. Humans. Lung / radiography. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18417859.001).
  • [ISSN] 0377-4929
  • [Journal-full-title] Indian journal of pathology & microbiology
  • [ISO-abbreviation] Indian J Pathol Microbiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


23. Blanco M, García-Fontán E, Rivo JE, Repáaz JR, Obeso GA, Cañizares MA: Bronchogenic carcinoma in patients under 50 years old. Clin Transl Oncol; 2009 May;11(5):322-5
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bronchogenic carcinoma in patients under 50 years old.
  • INTRODUCTION: Lung cancer in young patients is increasing in frequency.
  • Our objective is to assess the clinicopathologic characteristics and survival of patients with bronchogenic carcinoma who underwent surgery at our department, comparing people younger than 50 years to older patients.
  • MATERIALS AND METHODS: We present a retrospective study of 610 patients diagnosed with non-small-cell lung cancer operated on between 1997 and 2006.
  • CONCLUSIONS: In our series, despite the differences in sex, smoking history and histology, the behaviour of the disease is similar in both age groups.
  • [MeSH-major] Carcinoma, Bronchogenic / mortality. Carcinoma, Bronchogenic / pathology. Lung Neoplasms / mortality. Lung Neoplasms / pathology
  • [MeSH-minor] Adult. Age Factors. Aged. Female. Humans. Kaplan-Meier Estimate. Male. Middle Aged. Neoplasm Staging. Sex Factors. Smoking / adverse effects

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19451066.001).
  • [ISSN] 1699-048X
  • [Journal-full-title] Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
  • [ISO-abbreviation] Clin Transl Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


24. Horne ZD, Landreneau RJ, Luketich JD, Schuchert MJ: Endoluminal management of bronchogenic carcinoma in 2010: diagnosis, staging, and therapy. Minerva Chir; 2010 Dec;65(6):635-54
The Weizmann Institute of Science GeneCards and MalaCards databases. gene/protein/disease-specific - MalaCards for bronchogenic carcinoma .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endoluminal management of bronchogenic carcinoma in 2010: diagnosis, staging, and therapy.
  • Endoluminal bronchogenic carcinoma, though a minority of lung cancer cases, presents a unique opportunity to utilize techniques for the diagnosis and therapy that are unavailable for more peripheral tumors.
  • This review explores current techniques for the diagnosis, staging, and therapy of endoluminal central bronchogenic tumors and also introduces techniques currently under investigation as potential improvements or replacements for current techniques using recent literature.
  • Additionally, the new staging criteria set forth in the 7th edition of the TMN staging system as a result of the American Joint Committee on Cancer (AJCC), International Union Against Cancer (IUCC), and the International Association for the Study of Lung Cancer (IASLC) are discussed with respect to endoluminal bronchogenic carcinoma.
  • [MeSH-major] Carcinoma, Bronchogenic / diagnosis. Carcinoma, Bronchogenic / surgery. Lung Neoplasms / diagnosis. Lung Neoplasms / surgery
  • [MeSH-minor] Biopsy / methods. Bronchoscopes. Bronchoscopy / methods. Decision Trees. Equipment Design. Humans. Neoplasm Staging

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21224798.001).
  • [ISSN] 0026-4733
  • [Journal-full-title] Minerva chirurgica
  • [ISO-abbreviation] Minerva Chir
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Italy
  •  go-up   go-down


25. Xu L, Yu M, Yuan F, Qiu N, Huang J, Lu X, Zhang Z: [Experience of carinal resection and reconstruction in the treatment of carinal tumor and bronchogenic carcinoma]. Zhongguo Fei Ai Za Zhi; 2006 Feb 20;9(1):9-13

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Experience of carinal resection and reconstruction in the treatment of carinal tumor and bronchogenic carcinoma].
  • BACKGROUND: Carinal resection and reconstruction is an emphasis in surgical treatment of carinal tumor and bronchogenic carcinoma involving carina.
  • The aim of this study is to discuss the clinical value of carinoplasty in lung cancer surgery.
  • METHODS: From 1982 to 2004, 41 cases of central bronchogenic carcinoma that invaded the carina accepted carinal resection and reconstruction in this hospital.
  • CONCLUSIONS: The carinoplasty is a good method to treat central bronchogenic carcinoma which invaded the carina.
  • With this method lung cancer tissue can be resected maximally, meanwhile, it can save pulmonary function of patient maximally.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21144272.001).
  • [ISSN] 1009-3419
  • [Journal-full-title] Zhongguo fei ai za zhi = Chinese journal of lung cancer
  • [ISO-abbreviation] Zhongguo Fei Ai Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


26. Jiang F, Xu L, Yuan F, Huang J, Lu X, Zhang Z: Carinal resection and reconstruction in surgical treatment of bronchogenic carcinoma with carinal involvement. J Thorac Oncol; 2009 Nov;4(11):1375-9
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Carinal resection and reconstruction in surgical treatment of bronchogenic carcinoma with carinal involvement.
  • The aim of this study is to discuss the clinical value of carinoplasty in the surgical treatment of bronchogenic carcinoma involving carina.
  • MATERIALS AND METHODS: From 1982 to 2006, 41 cases of centrally placed bronchogenic carcinoma invading the carina were treated with carinal resection and reconstruction in our hospital.
  • Survival was better in patients with N0-1 disease than those with N2 disease (37.0% versus 7.1% at 5 years).
  • CONCLUSION: Carinoplasty for bronchogenic carcinoma involving carina is feasible with acceptable morbidity and mortality if patients are selected carefully.
  • [MeSH-major] Carcinoma, Bronchogenic / surgery. Lung Neoplasms / surgery. Trachea / surgery. Tracheal Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Anastomosis, Surgical. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Invasiveness. Reconstructive Surgical Procedures / methods. Retrospective Studies. Time Factors. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19745770.001).
  • [ISSN] 1556-1380
  • [Journal-full-title] Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
  • [ISO-abbreviation] J Thorac Oncol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


27. Mir NA, Baba AN, Ahmad SM, Paljor SD, Bhat JA: Big toe metastases as first clinical sign of occult bronchogenic carcinoma. J Coll Physicians Surg Pak; 2010 Oct;20(10):699-700
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Big toe metastases as first clinical sign of occult bronchogenic carcinoma.
  • Metastasis to bone is a common manifestation of malignant tumours.
  • We report a rare case of pain and destruction of the distal phalanx of great toe, initially suspected as osteomyelitis, which on biopsy proved to be metastases from a clinically silent bronchogenic carcinoma.
  • [MeSH-major] Bone Neoplasms / secondary. Carcinoma, Bronchogenic / secondary. Hallux. Lung Neoplasms / pathology. Toe Phalanges
  • [MeSH-minor] Diagnosis, Differential. Humans. Male. Middle Aged. Osteomyelitis / diagnosis

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20943119.001).
  • [ISSN] 1022-386X
  • [Journal-full-title] Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
  • [ISO-abbreviation] J Coll Physicians Surg Pak
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Pakistan
  •  go-up   go-down


28. Poncelet AJ, Watremez C, Tack D, Noirhomme P: Paracardiac opacity following inferior- and middle-lobe resection for bronchogenic carcinoma: unsuspected diagnosis. Chest; 2005 Jul;128(1):439-41
MedlinePlus Health Information. consumer health - Foreign Bodies.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Paracardiac opacity following inferior- and middle-lobe resection for bronchogenic carcinoma: unsuspected diagnosis.
  • We report the case of a patient who had benefited initially from a right middle and lower lobectomy for bronchogenic carcinoma and who had an extensive radiologic workup in an outside hospital in the early postoperative period.
  • Based on CT scan findings, this patient was referred back with a diagnosis that conveys both medical and medicolegal issues: a gossypiboma (or retained surgical sponge).
  • [MeSH-major] Carcinoma, Bronchogenic / surgery. Foreign Bodies / radiography. Surgical Sponges
  • [MeSH-minor] Aged. Diagnosis, Differential. Humans. Male. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16002969.001).
  • [ISSN] 0012-3692
  • [Journal-full-title] Chest
  • [ISO-abbreviation] Chest
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


29. Bahar I, Weinherger D, Kremer MR, Starobin D, Kramer M: [Ocular manifestation of bronchogenic carcinoma: simultaneous occurrence of diffuse uveal melanocytic proliferation and uveal metastases]. Harefuah; 2007 Jan;146(1):2-3, 80
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Ocular manifestation of bronchogenic carcinoma: simultaneous occurrence of diffuse uveal melanocytic proliferation and uveal metastases].
  • Systemic cancer may affect the eye and orbit as metastatic disease or paraneoplastic retinal degeneration.
  • This is a case report of a 55-year-old man with unilateral visual loss as the presenting symptom of metastatic adenocarcinoma of lung in one eye and diffuse uveal melanocytic proliferation in the other.
  • In heavy smokers, bronchogenic carcinoma should be highly suspected.
  • [MeSH-major] Carcinoma, Bronchogenic / pathology. Lung Neoplasms / pathology. Uvea / pathology. Uveal Neoplasms / secondary

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17294837.001).
  • [ISSN] 0017-7768
  • [Journal-full-title] Harefuah
  • [ISO-abbreviation] Harefuah
  • [Language] heb
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Israel
  •  go-up   go-down


30. Habeşoğlu MA, Oğuzülgen KI, Oztürk C, Akyürek N, Memiş L: A case of bronchogenic carcinoma presenting with acute abdomen. Tuberk Toraks; 2005;53(3):280-3
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A case of bronchogenic carcinoma presenting with acute abdomen.
  • Colonic metastasis of the bronchogenic carcinoma is quite rare.
  • Here we document an extremely rare presentation of the lung cancer that presented with acute abdomen and was diagnosed as intestinal obstruction due to colon carcinoma initially.
  • He underwent an urgent operation and the obliterating mass in the colon was resected and reported as "colon metastasis from epidermoid carcinoma probably of the lung".
  • Afterwards bronchoscopy revealed an endobronchial lesion in the right lower lobe that was diagnosed as poorly differentiated squamous cell lung carcinoma.
  • In this case, colon metastasis was diagnosed before the diagnosis of the primary disease.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Carcinoma, Bronchogenic / pathology. Carcinoma, Squamous Cell / secondary. Colonic Neoplasms / secondary. Lung Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16258889.001).
  • [ISSN] 0494-1373
  • [Journal-full-title] Tüberküloz ve toraks
  • [ISO-abbreviation] Tuberk Toraks
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Turkey
  •  go-up   go-down


31. Zhang P, Chen G, Liu Y, Han F: [Bronchoplasties and pulmonary arterioplasties in the treatment of central-type bronchogenic carcinoma]. Zhongguo Fei Ai Za Zhi; 2006 Feb 20;9(1):25-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Bronchoplasties and pulmonary arterioplasties in the treatment of central-type bronchogenic carcinoma].
  • In this article our experience with arterioplastic and bronchoplastic procedures in the treatment of central-type bronchogenic carcinoma was reviewed.
  • METHODS: From October 1999 to October 2005, 12 pulmonary arterioplasties and 14 combined broncho-angioplasties were performed for bronchogenic carcinoma and meanwhile two replacement of vena cava were done.
  • Atelectasis occurred in 2 patients (7.7%), postoperative pneumonitis in 2 (7.7%), and reperfusion lung injury in one (3.8%).
  • Angioplastic and combined broncho-angioplastic procedures offer patients with bronchogenic carcinoma similar a long-term result as radical lung resection, especially in patients who cannot tolerate pneumonectomy due to poor cardiopulmonary reserve.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21144276.001).
  • [ISSN] 1009-3419
  • [Journal-full-title] Zhongguo fei ai za zhi = Chinese journal of lung cancer
  • [ISO-abbreviation] Zhongguo Fei Ai Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


32. Vahid B, Leone FT: The solitary pulmonary nodule: not always bronchogenic carcinoma. Prim Care Respir J; 2006 Aug;15(4):256-8
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The solitary pulmonary nodule: not always bronchogenic carcinoma.
  • A solitary lung nodule (SLN) is seen in 1 in 500 chest radiographs.
  • Bronchogenic carcinoma and solitary pulmonary metastases are found in 35% and 23% of SLN's respectively.
  • Primary pulmonary non-Hodgkins lymphoma is a rare disease, constituting 0.4% of all lymphomas.
  • We present a case of primary pulmonary non-Hodgkins lymphoma which presented as a SLN in an 87-year old lady with a smoking history of 50 pack years.
  • [MeSH-major] Lung Neoplasms / complications. Lymphoma, B-Cell / complications. Lymphoma, Non-Hodgkin / complications. Solitary Pulmonary Nodule / etiology
  • [MeSH-minor] Aged, 80 and over. Carcinoma, Bronchogenic / diagnosis. Diagnosis, Differential. Female. Humans

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16854629.001).
  • [ISSN] 1471-4418
  • [Journal-full-title] Primary care respiratory journal : journal of the General Practice Airways Group
  • [ISO-abbreviation] Prim Care Respir J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


33. Prasad R, Ahuja RC, Singhal S, Srivastava AN, James P, Kesarwani V, Singh D: A case-control study of bidi smoking and bronchogenic carcinoma. Ann Thorac Med; 2010 Oct;5(4):238-41

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A case-control study of bidi smoking and bronchogenic carcinoma.
  • OBJECTIVE: To evaluate the risks imposed by tobacco smoking, in particular, bidi smoking, in the development of lung cancer.
  • METHODS: Two hundred eighty-four histologically confirmed patients of bronchogenic carcinoma and 852 controls matched for age, sex, and socioeconomic status were interviewed according to a predesigned questionnaire.
  • RESULTS: 81.3% cases of bronchogenic carcinoma were ever smokers as compared with 42.2% among controls.
  • CONCLUSION: Bidi smoking poses a very high risk for lung cancer even more than that of cigarette smoking.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20981185.001).
  • [ISSN] 1998-3557
  • [Journal-full-title] Annals of thoracic medicine
  • [ISO-abbreviation] Ann Thorac Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC2954379
  • [Keywords] NOTNLM ; Bidi / cigarette / epidemiology / lung cancer / tobacco
  •  go-up   go-down


34. García Luján R, Hisado Díaz MD, Miguel Poch E, Alfaro Abreu J: [Endoscopic techniques in bronchogenic carcinoma. Changes in recent decades]. Rev Clin Esp; 2010 Oct;210(9):457-61
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Endoscopic techniques in bronchogenic carcinoma. Changes in recent decades].
  • [Transliterated title] Técnicas endoscópicas en carcinoma broncogénico. Cambios en las últimas décadas.
  • Which additional studies do you consider to be indicated for a correct diagnosis and mediastinal staging?
  • Do bronchoscopy techniques alone establish the final diagnosis and staging of this patient?
  • [MeSH-major] Bronchoscopy. Carcinoma, Bronchogenic / diagnosis. Lung Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2009 Elsevier España, S.L. All rights reserved.
  • (PMID = 20846647.001).
  • [ISSN] 1578-1860
  • [Journal-full-title] Revista clínica española
  • [ISO-abbreviation] Rev Clin Esp
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


35. Minai OA, Shah S, Mazzone P, Budev MM, Sahoo D, Murthy S, Mason D, Pettersson G, Mehta AC: Bronchogenic carcinoma after lung transplantation: characteristics and outcomes. J Thorac Oncol; 2008 Dec;3(12):1404-9
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bronchogenic carcinoma after lung transplantation: characteristics and outcomes.
  • BACKGROUND: Lung cancer may occur in the lung transplant population because many patients are former smokers.
  • METHODS: We performed a search of the lung transplant database at our institution to identify patients who had been diagnosed with lung cancer.
  • Records and reports were reviewed for demographics, risk factors for malignancy, lung transplant characteristics, radiographic characteristics, treatment, and outcomes.
  • RESULTS: We identified 12 lung transplant patients with bronchogenic carcinoma at our institution [age 47.2 +/- 13.2 years (mean +/- SD); 7 (58%) men and 5 (42%) women].
  • Eleven patients were transplanted for chronic obstructive pulmonary disease (COPD).
  • Time from transplantation to diagnosis of cancer was 119 (21-416) [mean (range)] weeks.
  • Eleven cancers occurred in the native lung; most common cancer cell types were adenocarcinoma (N = 5).
  • Incidence among patients with COPD, who received single lung transplantation was 5.15%.
  • Time from diagnosis of bronchogenic carcinoma to death was 10.8 (1-60) [mean (range)] weeks with a 75% (9/12) 1-year mortality.
  • CONCLUSIONS: Among our patients, almost all cancers occurred in native lung in ex-smokers who received a lung transplant for COPD.
  • The cancer was often an incidental finding on a routine chest radiograph; however, the disease was usually at an advanced stage at diagnosis, limiting therapeutic options.
  • [MeSH-major] Carcinoma, Bronchogenic / etiology. Lung Neoplasms / etiology. Lung Transplantation / adverse effects. Pulmonary Disease, Chronic Obstructive / surgery
  • [MeSH-minor] Adult. Aged. Female. Follow-Up Studies. Humans. Incidence. Male. Middle Aged. Neoplasm Recurrence, Local / diagnosis. Neoplasm Recurrence, Local / etiology. Risk Factors. Treatment Outcome

  • Genetic Alliance. consumer health - Transplantation.
  • MedlinePlus Health Information. consumer health - COPD.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Lung Transplantation.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Thorac Oncol. 2008 Dec;3(12):1377-8 [19057259.001]
  • (PMID = 19057264.001).
  • [ISSN] 1556-1380
  • [Journal-full-title] Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
  • [ISO-abbreviation] J Thorac Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


36. Teschner M, Durisin M, Mangold A, Lenarz T, Stöver T: [Peripheral facial palsy as the first symptom of a metastatic bronchogenic carcinoma]. Laryngorhinootologie; 2006 Jul;85(7):512-6
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Peripheral facial palsy as the first symptom of a metastatic bronchogenic carcinoma].
  • BACKGROUND: We present a case of a facial palsy as the initial symptom of a bronchogenic carcinoma.
  • The following thorax CT as well as the diagnostic extirpation of an enlarged cervical lymph node lead to the diagnosis of a metastasized smallcell neuro-endocrine bronchogenic carcinoma with a compression of the right primary bronchus and the vena cava superior as well as an upper inflow congestion.
  • RESULTS: According to the present findings, this metastasis lead to the facial palsy as the initial symptom of the bronchogenic carcinoma.
  • [MeSH-major] Brain Neoplasms / secondary. Carcinoma, Bronchogenic. Facial Paralysis / etiology. Lung Neoplasms. Skull Neoplasms / secondary. Temporal Bone
  • [MeSH-minor] Cerebellar Neoplasms / diagnosis. Cerebellar Neoplasms / mortality. Cerebellar Neoplasms / secondary. Cerebellar Neoplasms / therapy. Combined Modality Therapy. Glossopharyngeal Nerve Diseases / diagnosis. Glossopharyngeal Nerve Diseases / etiology. Humans. Jugular Veins. Magnetic Resonance Imaging. Male. Middle Aged. Paralysis / diagnosis. Paralysis / etiology. Prognosis. Radiography, Thoracic. Time Factors. Tomography, X-Ray Computed. Venous Thrombosis / radiography

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16791767.001).
  • [ISSN] 0935-8943
  • [Journal-full-title] Laryngo- rhino- otologie
  • [ISO-abbreviation] Laryngorhinootologie
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


37. Kushwaha RA, Verma SK, Mehra S, Prasad R: Pulmonary and nodal multiple myeloma with a pleural effusion mimicking bronchogenic carcinoma. J Cancer Res Ther; 2009 Oct-Dec;5(4):297-9
MedlinePlus Health Information. consumer health - Multiple Myeloma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pulmonary and nodal multiple myeloma with a pleural effusion mimicking bronchogenic carcinoma.
  • Hereby, we describe a case of a patient with pulmonary plasmacytoma, who developed nodal and pulmonary MM with a pleural effusion, the radiological appearance of which mimicked bronchogenic carcinoma.
  • [MeSH-major] Carcinoma, Bronchogenic / pathology. Lung Neoplasms / pathology. Multiple Myeloma / pathology. Pleural Effusion, Malignant / etiology
  • [MeSH-minor] Diabetes Mellitus. Diagnosis, Differential. Humans. Male. Middle Aged

  • Genetic Alliance. consumer health - Multiple myeloma.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20160366.001).
  • [ISSN] 1998-4138
  • [Journal-full-title] Journal of cancer research and therapeutics
  • [ISO-abbreviation] J Cancer Res Ther
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


38. Zhang Y, Le H, Chen Z, Wang C, Zhang B: [Study on relationship between blood supply from pulmonary artery and pathological characteristics of patients with primary bronchogenic carcinoma]. Zhongguo Fei Ai Za Zhi; 2006;9(4):333-6

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Study on relationship between blood supply from pulmonary artery and pathological characteristics of patients with primary bronchogenic carcinoma].
  • BACKGROUND: At present, it has been known that the bronchogenic artery participates in the blood supply of primary bronchogenic carcinoma, but there is controversy about the blood supply from pulmonary artery in primary bronchogenic carcinoma.
  • The aim of this study is to assess the relationship between the blood supply from pulmonary artery and pathological characteristis of patients with primary bronchogenic carcinoma.
  • METHODS: The pulmonary arteries in 43 surgical samples of bronchogenic carcinoma were marked, then the iopromide was used to selective pulmonary arteriography in digital subtraction angiography (DSA).
  • The development rate of peripheral lung cancer (100.00%) was significantly higher than that of central lung cancer (64.00%) (P < 0.01) .
  • The development rate of squamous cell carcinoma (91.30%) was remarkably higher than that of adenocarcinoma (61.11%) (P < 0.05).
  • The development rate of poorly differentiated lung cancer (95.00%) was remarkably higher than that of well and moderately differentiated lung cancer (65.22%) (P < 0.05).
  • CONCLUSIONS: In primary bronchogenic carcinoma, the pulmonary artery blood supply exists in most of tumors.
  • There is relationship between the blood supply from pulmonary artery and general type, histopathology, cell differentiation and tumor size of lung cancer.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21176449.001).
  • [ISSN] 1009-3419
  • [Journal-full-title] Zhongguo fei ai za zhi = Chinese journal of lung cancer
  • [ISO-abbreviation] Zhongguo Fei Ai Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


39. Wang MZ, Chen Y, Zhong W, Zhang L, Xu L, Shi JH, Zhong X, Xiao Y, Cai BQ, Li LY: [Transbronchial needle aspiration in the diagnosis of bronchogenic carcinoma with enlarged mediastinal and /or hilar lymph nodes]. Zhonghua Zhong Liu Za Zhi; 2006 Jul;28(7):533-5
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Transbronchial needle aspiration in the diagnosis of bronchogenic carcinoma with enlarged mediastinal and /or hilar lymph nodes].
  • OBJECTIVE: To evaluate the role of transbronchial needle aspiraion (TBNA) in the diagnosis of bronchogenic carcinoma with enlarged mediastinal and/or hilar lymph node.
  • RESULTS: From June 2004 to May 2006, 77 such patients were examined: including 38 lung cancers, 35 lung benign diseases and 4 without definite diagnosis.
  • Positive TBNA rate was 81.6% (31/38) in patients who had been proven to suffer from bronchogenic carcinoma.
  • The diagnosis of lung cancer was confirmed via TBNA only in 9 patients.
  • A total of 63 lymph nodes in the 38 lung cancer patients were aspirated by TBNA with a positive rate of 65.1% (41/63).
  • CONCLUSION: TBNA is quite safe and helpful in diagnosis and staging of bronchogenic carcinoma, yet it is not helpful in diagnosis of benign lung diseases.
  • [MeSH-major] Biopsy, Fine-Needle / methods. Carcinoma, Bronchogenic / pathology. Carcinoma, Non-Small-Cell Lung / pathology. Lung Neoplasms / pathology. Lymph Nodes / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Bronchoscopy. Carcinoma, Small Cell / pathology. Diagnosis, Differential. Female. Humans. Male. Mediastinum. Middle Aged. Reproducibility of Results

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17147121.001).
  • [ISSN] 0253-3766
  • [Journal-full-title] Zhonghua zhong liu za zhi [Chinese journal of oncology]
  • [ISO-abbreviation] Zhonghua Zhong Liu Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


40. Penha DS, Salge AK, Tironi F, Saldanha JC, Castro EC, Teixeira Vde P, dos Reis MA: Bronchogenic carcinoma of squamous cells in a young pregnant woman. Ann Diagn Pathol; 2006 Aug;10(4):235-8
MedlinePlus Health Information. consumer health - Tumors and Pregnancy.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bronchogenic carcinoma of squamous cells in a young pregnant woman.
  • Lung cancer continues to be the most incident neoplasia in the world and also the most frequent cause of death by cancer, with more than 900000 new cases per year.
  • Women present greater risk of developing bronchogenic carcinoma, possibly because of differences in metabolism of the carcinogens associated with tobacco and also because of hormonal differences because estrogens can promote the appearance of lung cancer, including during pregnancy.
  • We have described the case of a 25-year-old patient who developed squamous cell carcinoma of the lung during her third pregnancy, with a progressive worsening of her general condition and progression until death.
  • We believe that the pregnancy could have contributed to the evolution of the disease, especially because of the increased levels of gestational hormones, particularly the estrogen, because its receptors have an important role in regulating growth and in the differentiation of several tissues facilitating like this, the development of the neoplasia, and complicating its early diagnosis.
  • [MeSH-major] Carcinoma, Bronchogenic / pathology. Carcinoma, Squamous Cell / pathology. Pregnancy Complications, Neoplastic / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16844566.001).
  • [ISSN] 1092-9134
  • [Journal-full-title] Annals of diagnostic pathology
  • [ISO-abbreviation] Ann Diagn Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


41. Shahid M, Malik A, Bhargava R: Bronchogenic carcinoma and secondary aspergillosis--common yet unexplored: evaluation of the role of bronchoalveolar lavage-polymerase chain reaction and some nonvalidated serologic methods to establish early diagnosis. Cancer; 2008 Aug 1;113(3):547-58
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bronchogenic carcinoma and secondary aspergillosis--common yet unexplored: evaluation of the role of bronchoalveolar lavage-polymerase chain reaction and some nonvalidated serologic methods to establish early diagnosis.
  • BACKGROUND: More cases of bronchogenic carcinoma have been reported in recent years, and these patients are more prone to secondary aspergillosis.
  • However, the frequency of secondary aspergillosis in bronchogenic carcinoma still has not been defined clearly in the literature.
  • METHODS: The current study population was comprised of 69 patients with bronchogenic carcinoma and 16 healthy controls.
  • Histopathologic examination was done to identify carcinoma cell types and to categorize aspergillosis types.
  • RESULTS: The cohort included patients with squamous cell carcinoma (n = 47), adenocarcinoma (n = 16), small cell carcinoma (n = 3), large cell carcinoma (n = 2), and undiagnosed type (n = 1), and patients were categorized with definite invasive pulmonary aspergillosis (IPA) (n = 6), probable IPA (n = 17), possible IPA (n = 13), and non-IPA (n = 33).
  • CONCLUSIONS: The current study indicated that there frequently is an association between bronchogenic carcinoma and secondary aspergillosis, and definite IPA and probable IPA are common clinical problems in patients with nonsmall cell lung cancer.
  • [MeSH-major] Aspergillosis / diagnosis. Bronchoalveolar Lavage Fluid / chemistry. Carcinoma, Bronchogenic / diagnosis. Lung Neoplasms / diagnosis. Polymerase Chain Reaction / methods. Serologic Tests / methods
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Algorithms. Aspergillus fumigatus / immunology. Case-Control Studies. Cells, Cultured. Early Diagnosis. Female. Humans. Lung Diseases, Fungal. Male. Microbial Sensitivity Tests. Middle Aged. Validation Studies as Topic

  • Genetic Alliance. consumer health - Aspergillosis.
  • MedlinePlus Health Information. consumer health - Aspergillosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2008 American Cancer Society
  • (PMID = 18521930.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] eng
  • [Publication-type] Comparative Study; Evaluation Studies; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


42. Uskul BT, Turker H, Bayraktar OU, Onemli M: Bronchogenic carcinoma developing during a long-term course of pulmonary Langerhans' cell histiocytosis. Intern Med; 2009;48(5):359-62
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bronchogenic carcinoma developing during a long-term course of pulmonary Langerhans' cell histiocytosis.
  • HRCT of the thorax demonstrated the presence of diffuse emphysematous areas in both lungs with a honeycomb appearance, an increase in reticular density at the lower lobes, a mass lesion in the left hilus, and a mass lesion at the lower lobe of the left lung.
  • Histological diagnosis of TBNA from the right lower paratracheal and subcarinal lymph nodes was adenocarcinoma.
  • We present this case as an example of the rare development of bronchogenic carcinoma during the long-term course of LCH.
  • [MeSH-major] Adenocarcinoma / etiology. Histiocytosis, Langerhans-Cell / complications. Lung Neoplasms / etiology
  • [MeSH-minor] Adult. Disease Progression. Drug Therapy. Fatal Outcome. Humans. Male

  • Genetic Alliance. consumer health - Histiocytosis.
  • Genetic Alliance. consumer health - Langerhans cell histiocytosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19252362.001).
  • [ISSN] 1349-7235
  • [Journal-full-title] Internal medicine (Tokyo, Japan)
  • [ISO-abbreviation] Intern. Med.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


43. Camargo JJ, Camargo SM, Machuca TN, Perin FA: Round pneumonia: a rare condition mimicking bronchogenic carcinoma. Case report and review of the literature. Sao Paulo Med J; 2008 Jul;126(4):236-8
MedlinePlus Health Information. consumer health - Pneumonia.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Round pneumonia: a rare condition mimicking bronchogenic carcinoma. Case report and review of the literature.
  • It is an oval-shaped consolidation that, due to its radiological appearance, simulates bronchogenic carcinoma.
  • CASE REPORT: The case of a 54-year-old female patient presenting a lung mass found on routine imaging evaluation is reported.
  • On chest radiographs, a mass located in the middle third of the right lung was observed.
  • [MeSH-major] Carcinoma, Bronchogenic / radiography. Lung Neoplasms / radiography. Pneumonia / radiography
  • [MeSH-minor] Diagnosis, Differential. Female. Humans. Middle Aged

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18853036.001).
  • [ISSN] 1806-9460
  • [Journal-full-title] São Paulo medical journal = Revista paulista de medicina
  • [ISO-abbreviation] Sao Paulo Med J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Brazil
  • [Number-of-references] 13
  •  go-up   go-down


44. García de Llanos C, Cabrera Navarro P, Freixinet Gilart J, Rodríguez Suárez P, Hussein Serhald M, Romero Saavedra T: [Intrathoracic gossypiboma interpreted as bronchogenic carcinoma. Another false positive with positron emission tomography]. Arch Bronconeumol; 2007 May;43(5):292-4
MedlinePlus Health Information. consumer health - Foreign Bodies.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Intrathoracic gossypiboma interpreted as bronchogenic carcinoma. Another false positive with positron emission tomography].
  • [Transliterated title] Textiloma intratorácico interpretado como carcinoma broncogénico. Otro falso positivo de la tomografía por emisión de positrones.
  • Positron emission tomography (PET) is seldom used to diagnose gossypibomas and PET findings can result in false positives for a diagnosis of neoplastic disease.
  • The final diagnosis was gossypiboma, identified 23 years after pneumothorax surgery.
  • [MeSH-minor] Carcinoma, Bronchogenic / radionuclide imaging. Diagnosis, Differential. False Positive Reactions. Humans. Lung Neoplasms / radionuclide imaging. Male. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17519142.001).
  • [ISSN] 0300-2896
  • [Journal-full-title] Archivos de bronconeumología
  • [ISO-abbreviation] Arch. Bronconeumol.
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


45. Zili M, Hammami S, Marghli A, Mechmech L, Boughnim L, Abid S, Brahim N, Toumi Nel H, Kilani T, Yaalaoui S: [Acquired isolated factor VII deficiency and bronchogenic carcinoma. A case report]. Tunis Med; 2005 Jun;83(6):363-5
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Acquired isolated factor VII deficiency and bronchogenic carcinoma. A case report].
  • [Transliterated title] Deficit acquis, isole en facteur VII et cancer bronchique. A propos d'un cas.
  • An acquired factor VII deficiency was identified in a 63-year-old man with bronchogenic carcinoma.
  • [MeSH-major] Factor VII Deficiency / etiology. Lung Neoplasms / complications

  • Genetic Alliance. consumer health - Factor VII Deficiency.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16156413.001).
  • [ISSN] 0041-4131
  • [Journal-full-title] La Tunisie médicale
  • [ISO-abbreviation] Tunis Med
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Tunisia
  •  go-up   go-down


46. Sun J, Han B, Zhang J, Zhao H, Qi D, Shen J, Gu A: [Role of endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of bronchogenic carcinoma]. Zhongguo Fei Ai Za Zhi; 2010 May;13(5):432-7
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Role of endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of bronchogenic carcinoma].
  • BACKGROUND AND OBJECTIVE: The aim of this study is to evaluate diagnostic yield and the safety of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in the diagnosis ofbronchogenic carcinoma.
  • RESULTS: In all 95 patients, 60 cases were newly diagnosed lung cancer through the pathological examination and clinical follow-up certification.
  • In 60 lung cancer cases, 112 samples were obtained from lymph nodes (LNs) and 11 samples were obtained from intrapulmonary lesions.
  • Sensitivity and specificity of EBUS-guided TBNA method in distinguishing benign from malignant LNs or thoracic masses were 96.67% and 100%, respectively.
  • CONCLUSION: EBUSTBNA seemed a safe and effective technique in making bronchogenic carcinoma diagnosis for mediastinal/hilar LNs and intra-pulmonary masses.
  • [MeSH-major] Biopsy, Fine-Needle / methods. Bronchi / pathology. Bronchi / ultrasonography. Carcinoma, Bronchogenic / diagnosis. Endosonography / methods. Lung Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20677637.001).
  • [ISSN] 1009-3419
  • [Journal-full-title] Zhongguo fei ai za zhi = Chinese journal of lung cancer
  • [ISO-abbreviation] Zhongguo Fei Ai Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  •  go-up   go-down


47. Graves TG, Harr MW, Crawford EL, Willey JC: Stable low-level expression of p21WAF1/CIP1 in A549 human bronchogenic carcinoma cell line-derived clones down-regulates E2F1 mRNA and restores cell proliferation control. Mol Cancer; 2006;5:1
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Stable low-level expression of p21WAF1/CIP1 in A549 human bronchogenic carcinoma cell line-derived clones down-regulates E2F1 mRNA and restores cell proliferation control.
  • BACKGROUND: Deregulated cell cycle progression and loss of proliferation control are key properties of malignant cells.
  • In previous studies, an interactive transcript abundance index (ITAI) comprising three cell cycle control genes, [MYC x E2F1]/p21 accurately distinguished normal from malignant bronchial epithelial cells (BEC), using a cut-off threshold of 7,000.
  • This cut-off is represented by a line with a slope of 7,000 on a bivariate plot of p21 versus [MYC x E2F1], with malignant BEC above the line and normal BEC below the line.
  • This study was an effort to better quantify, at the transcript abundance level, the difference between normal and malignant BEC.
  • The hypothesis was tested that experimental elevation of p21 in a malignant BEC line would decrease the value of the [MYC x E2F1]/p21 ITAI to a level below this line, resulting in loss of immortality and limited cell population doubling capacity.
  • In order to test the hypothesis, a p21 expression vector was transfected into the A549 human bronchogenic carcinoma cell line, which has low constitutive p21 TA expression relative to normal BEC.
  • Specifically, they provide experimental confirmation that a line with slope of 7,000 on the p21 versus [MYC x E2F1] bivariate plot quantifies the difference between normal and malignant BEC at the level of transcript abundance.
  • [MeSH-minor] Bronchi / metabolism. Carcinoma, Bronchogenic. Cell Line, Tumor. Cell Transformation, Neoplastic / metabolism. Clone Cells. Epithelial Cells / metabolism. Humans. Proto-Oncogene Proteins c-myc / genetics. Proto-Oncogene Proteins c-myc / metabolism. RNA, Messenger / metabolism. Transfection

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Oncogene. 1995 Nov 2;11(9):1675-83 [7478594.001]
  • [Cites] Oncogene. 1996 Jun 20;12(12):2579-94 [8700517.001]
  • [Cites] Am J Respir Cell Mol Biol. 1997 Jul;17(1):114-24 [9224217.001]
  • [Cites] Am J Respir Cell Mol Biol. 1998 Jul;19(1):6-17 [9651175.001]
  • [Cites] Am J Respir Cell Mol Biol. 1998 Jul;19(1):18-24 [9651176.001]
  • [Cites] Science. 1998 Nov 20;282(5393):1497-501 [9822382.001]
  • [Cites] Exp Cell Res. 1999 Feb 1;246(2):280-9 [9925742.001]
  • [Cites] Biochem Biophys Res Commun. 1999 Sep 16;263(1):35-40 [10486249.001]
  • [Cites] Oncogene. 1999 Sep 23;18(39):5381-92 [10498892.001]
  • [Cites] Am J Respir Cell Mol Biol. 2004 Dec;31(6):643-9 [15333326.001]
  • [Cites] Cancer Cell. 2004 Dec;6(6):577-86 [15607962.001]
  • [Cites] Oncogene. 2005 Apr 18;24(17):2810-26 [15838517.001]
  • [Cites] Mol Cancer. 2005;4(1):18 [15882455.001]
  • [Cites] Mol Cancer. 2005;4:23 [16014176.001]
  • [Cites] Nat Cell Biol. 1999 May;1(1):20-6 [10559859.001]
  • [Cites] J Biol Chem. 2000 Apr 7;275(14):10477-83 [10744738.001]
  • [Cites] Cancer Res. 2000 Mar 15;60(6):1609-18 [10749130.001]
  • [Cites] Mol Cell. 2000 Feb;5(2):403-10 [10882081.001]
  • [Cites] Genes Dev. 2000 Jul 1;14(13):1584-8 [10887152.001]
  • [Cites] Cancer Lett. 2000 Sep 29;158(1):73-84 [10940512.001]
  • [Cites] Mol Cell Biol. 2001 Jul;21(14):4684-99 [11416145.001]
  • [Cites] J Biol Chem. 2001 Nov 16;276(46):42971-7 [11559705.001]
  • [Cites] Lung Cancer. 2001 Dec;34 Suppl 2:S43-6 [11720740.001]
  • [Cites] Cancer Res. 2002 Mar 1;62(5):1305-10 [11888896.001]
  • [Cites] Oncogene. 2002 Jun 20;21(27):4220-30 [12082609.001]
  • [Cites] Mol Cell Biol. 2003 Jan;23(2):566-78 [12509455.001]
  • [Cites] CA Cancer J Clin. 2003 Jan-Feb;53(1):5-26 [12568441.001]
  • [Cites] Biosci Biotechnol Biochem. 2003 Apr;67(4):815-21 [12784623.001]
  • [Cites] J Mol Diagn. 2003 Aug;5(3):176-83 [12876208.001]
  • [Cites] Oncogene. 2003 Oct 23;22(48):7632-41 [14576826.001]
  • [Cites] Methods Mol Biol. 2004;258:13-41 [14970455.001]
  • [Cites] Chest. 2004 May;125(5 Suppl):155S-6S [15136482.001]
  • [Cites] Int J Oncol. 2004 Jun;24(6):1573-9 [15138602.001]
  • [Cites] J Hepatol. 2004 Oct;41(4):637-43 [15464245.001]
  • [Cites] Cytometry. 1983 Mar;3(5):323-7 [6188586.001]
  • [Cites] Differentiation. 1984;25(3):229-37 [6698333.001]
  • [Cites] Cancer Res. 1984 Nov;44(11):5124-6 [6488172.001]
  • [Cites] Anal Biochem. 1987 Apr;162(1):156-9 [2440339.001]
  • [Cites] Cell. 1993 Nov 19;75(4):805-16 [8242751.001]
  • [Cites] Cell. 1993 Nov 19;75(4):817-25 [8242752.001]
  • [Cites] Nature. 1993 Dec 16;366(6456):701-4 [8259214.001]
  • [Cites] Nature. 1993 Dec 16;366(6456):707-10 [8259216.001]
  • [Cites] Exp Cell Res. 1994 Mar;211(1):90-8 [8125163.001]
  • [Cites] Cell. 1994 Mar 25;76(6):1013-23 [8137420.001]
  • [Cites] Nature. 1994 Jun 16;369(6481):574-8 [7911228.001]
  • [Cites] J Biol Chem. 1994 Jun 24;269(25):17035-42 [8006008.001]
  • [Cites] Nature. 1994 Oct 6;371(6497):534-7 [7935768.001]
  • [Cites] Nature. 1995 Mar 23;374(6520):386-8 [7885482.001]
  • [Cites] Genes Dev. 1995 Aug 1;9(15):1831-45 [7649471.001]
  • (PMID = 16403226.001).
  • [ISSN] 1476-4598
  • [Journal-full-title] Molecular cancer
  • [ISO-abbreviation] Mol. Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / CDKN1A protein, human; 0 / Cyclin-Dependent Kinase Inhibitor p21; 0 / E2F1 Transcription Factor; 0 / E2F1 protein, human; 0 / MYC protein, human; 0 / Proto-Oncogene Proteins c-myc; 0 / RNA, Messenger
  • [Other-IDs] NLM/ PMC1368995
  •  go-up   go-down


48. Harr MW, Willey JC: The interactive transcript abundance index [c-myc*p73alpha]/[p21*Bcl-2] correlates with baseline level of apoptosis and response to CPT-11 in human bronchogenic carcinoma cell lines. Int J Oncol; 2007 Jun;30(6):1553-60
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The interactive transcript abundance index [c-myc*p73alpha]/[p21*Bcl-2] correlates with baseline level of apoptosis and response to CPT-11 in human bronchogenic carcinoma cell lines.
  • Currently available cytotoxic chemotherapy is ineffective for treating bronchogenic carcinoma, and this is partly due to unpredictable inter-tumor variation in resistance.
  • [MeSH-major] Antineoplastic Agents, Phytogenic / pharmacology. Apoptosis / genetics. Camptothecin / analogs & derivatives. Carcinoma, Bronchogenic / genetics. Drug Resistance, Neoplasm / genetics. Lung Neoplasms / genetics

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17487378.001).
  • [ISSN] 1019-6439
  • [Journal-full-title] International journal of oncology
  • [ISO-abbreviation] Int. J. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Phytogenic; 0 / Biomarkers, Tumor; 0 / MYC protein, human; 0 / Proto-Oncogene Proteins c-bcl-2; 0 / Proto-Oncogene Proteins c-myc; 0 / RNA Precursors; 7673326042 / irinotecan; XT3Z54Z28A / Camptothecin
  •  go-up   go-down


49. Mukherjee S, Bandyopadhyay G, Bhattacharya A, Ghosh R, Barui G, Karmakar R: Computed tomography-guided fine needle aspiration cytology of solitary pulmonary nodules suspected to be bronchogenic carcinoma: Experience of a general hospital. J Cytol; 2010 Jan;27(1):8-11

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Computed tomography-guided fine needle aspiration cytology of solitary pulmonary nodules suspected to be bronchogenic carcinoma: Experience of a general hospital.
  • BACKGROUND: Fine needle aspiration cytology (FNAC) may be diagnostic in candidates with indeterminate solitary pulmonary nodules (SPNs) suspicious of bronchogenic carcinoma.
  • MATERIALS AND METHODS: All the cases had a strong clinical suspicion of lung cancer, negative bronchoscopy, negative sputum cytology for malignant cells and acid fast bacilli.
  • A thorough radiological evaluation was made to rule out primary malignancy elsewhere.
  • The cytological diagnosis was correlated with clinical-radiological follow-up and biopsy to arrive at a final diagnosis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21042527.001).
  • [ISSN] 0974-5165
  • [Journal-full-title] Journal of cytology
  • [ISO-abbreviation] J Cytol
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC2964851
  • [Keywords] NOTNLM ; Bronchogenic carcinoma / computed tomography / fine needle aspiration cytology
  •  go-up   go-down


50. Ramnath N, Demmy TL, Antun A, Natarajan N, Nwogu CE, Loewen GM, Reid ME: Pneumonectomy for bronchogenic carcinoma: analysis of factors predicting survival. Ann Thorac Surg; 2007 May;83(5):1831-6
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pneumonectomy for bronchogenic carcinoma: analysis of factors predicting survival.
  • BACKGROUND: The aim of this study was to identify risk factors associated with survival after pneumonectomy for non-small cell lung cancer.
  • METHODS: This was a retrospective study of 155 patients who underwent a pneumonectomy for non-small cell lung cancer at Roswell Park Cancer Institute between 1986 and 2002.
  • Squamous cell carcinoma (54%) and adenocarcinoma (33%) were the predominant histologic types.
  • Pneumonectomy for non-small cell lung cancer carries an acceptable operative mortality and provides an important survival benefit.
  • [MeSH-major] Adenocarcinoma / surgery. Carcinoma, Bronchogenic / surgery. Carcinoma, Squamous Cell / surgery. Lung Neoplasms / surgery. Pneumonectomy / mortality

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17462408.001).
  • [ISSN] 1552-6259
  • [Journal-full-title] The Annals of thoracic surgery
  • [ISO-abbreviation] Ann. Thorac. Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


51. Nair G, Swami S, Mehta A: Idiopathic pulmonary fibrosis with bronchogenic carcinoma. Lung India; 2009 Apr;26(2):51-2

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Idiopathic pulmonary fibrosis with bronchogenic carcinoma.
  • Idiopathic pulmonary fibrosis is essentially a benign disease.
  • Biopsy of the mass revealed a squamous cell carcinoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Thorax. 2007 Jan;62(1):62-6 [16769717.001]
  • [Cites] Thorax. 1980 Jul;35(7):496-9 [7434310.001]
  • [Cites] Am J Respir Crit Care Med. 2000 Jan;161(1):5-8 [10619790.001]
  • (PMID = 20440396.001).
  • [ISSN] 0974-598X
  • [Journal-full-title] Lung India : official organ of Indian Chest Society
  • [ISO-abbreviation] Lung India
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC2860416
  • [Keywords] NOTNLM ; Interstitial pulmonary fibrosis / lung cancer / wood smoke
  •  go-up   go-down


52. Ravenel JG, Mohammed TL, Movsas B, Ginsburg ME, Kirsch J, Kong FM, Parker JA, Reddy GP, Rosenzweig KE, Saleh AG, Expert Panels on Thoracic Imaging and Radiation Oncology–Lung: ACR Appropriateness Criteria® noninvasive clinical staging of bronchogenic carcinoma. J Thorac Imaging; 2010 Nov;25(4):W107-11
The Weizmann Institute of Science GeneCards and MalaCards databases. gene/protein/disease-specific - MalaCards for bronchogenic carcinoma .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] ACR Appropriateness Criteria® noninvasive clinical staging of bronchogenic carcinoma.
  • In order to appropriately manage patients with lung cancer, it is necessary to properly stage the tumor.
  • The ACR Appropriateness Criteria is designed to provide an overview of the value of different imaging techniques in the non-invasive staging of lung cancer and allow for the rational selection of imaging studies to arrive at the appropriate clinical stage.
  • [MeSH-major] Carcinoma, Bronchogenic / pathology. Lung Neoplasms / pathology. Neoplasm Staging / standards. Practice Guidelines as Topic. Radiology / methods. Small Cell Lung Carcinoma / pathology
  • [MeSH-minor] Adrenal Glands / pathology. Adrenal Glands / radiography. Adrenal Glands / radionuclide imaging. Bone and Bones / radionuclide imaging. Brain / pathology. Brain / radiography. Brain / radionuclide imaging. Humans. Liver / pathology. Lung / pathology. Lung / radiography. Lung / radionuclide imaging. Magnetic Resonance Imaging / methods. Neoplasm Metastasis. Positron-Emission Tomography / methods. Societies, Medical. Tomography, X-Ray Computed / methods. United States

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21042062.001).
  • [ISSN] 1536-0237
  • [Journal-full-title] Journal of thoracic imaging
  • [ISO-abbreviation] J Thorac Imaging
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  •  go-up   go-down


53. Veen EJ, Janssen-Heijnen ML, Ritchie ED, Biesma B, van den Bogart MP, Bolhuis RJ: Pneumonectomy for bronchogenic carcinoma: analysis of factors predicting short- and long-term outcome. Interact Cardiovasc Thorac Surg; 2009 Aug;9(2):260-4
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pneumonectomy for bronchogenic carcinoma: analysis of factors predicting short- and long-term outcome.
  • [MeSH-major] Carcinoma, Non-Small-Cell Lung / surgery. Lung Neoplasms / surgery. Pneumonectomy
  • [MeSH-minor] Adult. Age Factors. Aged. Aged, 80 and over. Comorbidity. Female. Humans. Logistic Models. Male. Middle Aged. Neoplasm Staging. Netherlands / epidemiology. Patient Selection. Proportional Hazards Models. Registries. Retrospective Studies. Risk Assessment. Risk Factors. Survival Analysis. Time Factors. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19443491.001).
  • [ISSN] 1569-9285
  • [Journal-full-title] Interactive cardiovascular and thoracic surgery
  • [ISO-abbreviation] Interact Cardiovasc Thorac Surg
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] England
  •  go-up   go-down


54. Bellil Y, Edelman MJ: Bronchogenic carcinoma in solid organ transplant recipients. Curr Treat Options Oncol; 2006 Jan;7(1):77-81
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bronchogenic carcinoma in solid organ transplant recipients.
  • There may be a 100-fold increase in the incidence of de novo neoplasia in this population.
  • Lung cancer is the most common cause of cancer death in the United States; therefore, lung cancer in patients undergoing organ transplantation would be expected to occur frequently on the basis of chance alone.
  • However, the lung cancer risk is approximately 20 to 25 times that of the general population, with an incidence of 0.28% to 4.1% in patients after heart and lung transplant.
  • The role of transplantation (and consequent therapy) in the development of lung cancer in this high-risk population remains unclear.
  • As in the nontransplant population, adequate screening techniques are lacking, making early diagnosis and treatment a challenge.
  • Despite close follow-up and routine imaging with chest radiography and CT, lung cancers continue to be discovered incidentally and at advanced stages.
  • [MeSH-major] Heart Transplantation / adverse effects. Liver Transplantation / adverse effects. Lung Neoplasms / etiology. Lung Transplantation / adverse effects


55. Liu D, Guo Y, Shi B, Tian Y, Song Z, Ma Q, Zhang Z, Ge B: Tracheal carinal reconstruction and bronchovasculoplasty in central type bronchogenic carcinoma. Zhongguo Fei Ai Za Zhi; 2010 Apr;13(4):352-6
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tracheal carinal reconstruction and bronchovasculoplasty in central type bronchogenic carcinoma.
  • BACKGROUND AND OBJECTIVE: Because radical resection for lung cancer invading the initial borderline of different lobes and carina is difficult, we tried to analyse the variables of successful tracheal carinoplasty and bronchovasculoplasty to discover a proper approach for appropriate early and long-term results.
  • METHODS: Of 1 399 lung resections for primary lung cancer performed in our hospital from April 1985 to December 2006, 133 underwent bronchoplastic surgeries, including 15 carinoplasty cases and 118 sleeve lobectomy (SL) cases, and 118 pneumoectomy (PN) cases were compared at the same time.
  • The 5 year survival rate by cancer stage was 69.2% for Ib, 40.6% for IIb, 19.6% for IIIa, and 16.6% for IIIa (N2).
  • CONCLUSION: Selection of cases, clearance of lymph nodes, disposal of the bronchus and pulmonary vessel and replacement or restoration of the superior vena cava are the main factors influencing prognosis.
  • [MeSH-major] Carcinoma, Bronchogenic / surgery. Lung Neoplasms / surgery. Trachea / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20677564.001).
  • [ISSN] 1009-3419
  • [Journal-full-title] Zhongguo fei ai za zhi = Chinese journal of lung cancer
  • [ISO-abbreviation] Zhongguo Fei Ai Za Zhi
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  •  go-up   go-down


56. Sanli M, Isik AF, Tuncozgur B, Akar E, Deniz H, Bakir K, Elbeyli L: The reliability of mediastinoscopic frozen sections in deciding on oncological surgery in bronchogenic carcinoma. Adv Ther; 2008 May;25(5):488-95
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The reliability of mediastinoscopic frozen sections in deciding on oncological surgery in bronchogenic carcinoma.
  • INTRODUCTION: This study was carried out to determine the accuracy of mediastinoscopic frozen section examination, performed prior to major surgery-especially where mediastinal lymph node metastasis (N2 disease) was suspected.
  • We aimed to find out whether or not mediastinoscopic frozen section analysis was (i) a reliable tool when deciding to continue resection in lung cancer patients and (ii) reliable in diagnosing mediastinal masses.
  • Thoracotomy and resection were performed when the results of frozen section examination were negative for malignancy in patients with lung cancer.
  • In the 105 patients with malignant diseases, these values were 93.33%, 100%, 100% and 91.84%, respectively.
  • CONCLUSIONS: It was confirmed that mediastinoscopy supported by frozen section examination plays an important role in establishing diagnosis and planning treatment both in benign and malignant diseases.
  • [MeSH-major] Carcinoma, Bronchogenic / surgery. Frozen Sections. Lung Neoplasms / surgery. Lymphatic Metastasis / diagnosis. Mediastinoscopy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18523735.001).
  • [ISSN] 0741-238X
  • [Journal-full-title] Advances in therapy
  • [ISO-abbreviation] Adv Ther
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


57. Sen J, Clewes AR, Quah SA, Hiscott PS, Bucknall RC, Damato BE: Presymptomatic diagnosis of bronchogenic carcinoma associated with bilateral diffuse uveal melanocytic proliferation. Clin Exp Ophthalmol; 2006 Mar;34(2):156-8
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Presymptomatic diagnosis of bronchogenic carcinoma associated with bilateral diffuse uveal melanocytic proliferation.
  • The diagnosis was confirmed by trans-scleral biopsy of the right choroid.
  • [MeSH-major] Carcinoma, Bronchogenic / diagnosis. Choroid Diseases / pathology. Lung Neoplasms / diagnosis. Melanocytes / pathology. Paraneoplastic Syndromes / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16626431.001).
  • [ISSN] 1442-6404
  • [Journal-full-title] Clinical & experimental ophthalmology
  • [ISO-abbreviation] Clin. Experiment. Ophthalmol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


58. Campione A, Ligabue T, Luzzi L, Ghiribelli C, Paladini P, Voltolini L, Di Bisceglie M, D'Agata A, Gotti G: Late outcome and perioperative complications for surgery of locally recurrent bronchogenic carcinoma. J Cardiovasc Surg (Torino); 2005 Oct;46(5):515-8
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Late outcome and perioperative complications for surgery of locally recurrent bronchogenic carcinoma.
  • AIM: Many doubts involve a 2(nd) surgical approach for local relapse of non small cell lung cancer (NSCLC) since iterative resections represent a well-recognized treatment in second primary lung cancer (SPLC).
  • All patients submitted to 2(nd) operation were examined according to Martini and Melamed criteria to distinguish between local recurrence and second primary lung cancer.
  • Survival was better when the time between 1(st) resection and cancer relapse was longer than 14 months and when recurrence was intrapulmonary.
  • CONCLUSIONS: A new malignant lesion can be operated if it is solitary and intrapulmonary, if accurate staging is negative and if the patient is able to go through 2(nd) surgery from cardiopulmonary evaluation.
  • [MeSH-major] Carcinoma, Bronchogenic / surgery. Carcinoma, Non-Small-Cell Lung / surgery. Lung Neoplasms / surgery. Neoplasm Recurrence, Local / surgery. Pneumonectomy / adverse effects

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16278644.001).
  • [ISSN] 0021-9509
  • [Journal-full-title] The Journal of cardiovascular surgery
  • [ISO-abbreviation] J Cardiovasc Surg (Torino)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


59. Thomas BG, Maloney JD: Use of silfenadil for treatment of respiratory distress after pneumonectomy for bronchogenic carcinoma. Interact Cardiovasc Thorac Surg; 2007 Apr;6(2):262-3
Hazardous Substances Data Bank. SILDENAFIL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Use of silfenadil for treatment of respiratory distress after pneumonectomy for bronchogenic carcinoma.
  • Post-pneumonectomy respiratory failure is a devastating complication of resection for lung cancer.
  • [MeSH-major] Carcinoma, Bronchogenic / surgery. Lung Neoplasms / surgery. Nitric Oxide / metabolism. Nitric Oxide Donors / pharmacology. Piperazines / therapeutic use. Pneumonectomy / adverse effects. Respiratory Distress Syndrome, Adult / drug therapy. Sulfones / therapeutic use

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. NITRIC OXIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17669838.001).
  • [ISSN] 1569-9285
  • [Journal-full-title] Interactive cardiovascular and thoracic surgery
  • [ISO-abbreviation] Interact Cardiovasc Thorac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Nitric Oxide Donors; 0 / Piperazines; 0 / Purines; 0 / Sulfones; 31C4KY9ESH / Nitric Oxide; BW9B0ZE037 / Sildenafil Citrate
  •  go-up   go-down


60. Dickson RP, Davis RD, Rea JB, Palmer SM: High frequency of bronchogenic carcinoma after single-lung transplantation. J Heart Lung Transplant; 2006 Nov;25(11):1297-301
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] High frequency of bronchogenic carcinoma after single-lung transplantation.
  • BACKGROUND: Lung transplantation is a commonly employed therapy in the treatment of patients with advanced lung diseases related to tobacco use.
  • Little is known about the long-term incidence or risk factors for primary lung cancer after lung transplantation.
  • To determine the frequency, clinical features and risk factors for primary bronchogenic malignancy after lung transplantation, we designed a matched cohort study of single and bilateral lung transplant recipients with extended follow-up.
  • METHODS: We retrospectively reviewed the records of 262 lung transplant recipients who survived > or =90 days post-transplant and assessed for the development of primary lung cancer.
  • One hundred thirty-one consecutive single-lung transplant (SLTx) recipients were matched to 131 consecutive bilateral lung transplant (BLTx) recipients by native disease.
  • Risk factors for lung cancer development were derived using univariate and multivariate proportional hazards models.
  • RESULTS: Of the SLTx recipients, 6.9% developed primary lung cancer after transplantation as compared with 0% of the BLTx recipients (p = 0.002), after a mean of 52 months.
  • Histologically, non-small-cell cancers were present in the native lung, which led to death in 67% (6 of 9) of the patients despite treatment.
  • Significant risk factors for the development of primary lung cancer were increasing age (p = 0.004), >60-pack-year smoking history (p = 0.03), and SLTx as compared with BLTx (p < 0.001).
  • CONCLUSIONS: Single-lung transplant confers a significantly elevated risk of developing primary post-transplant lung cancer as compared with BLTx in patients with comparable native disease, age and tobacco history.
  • [MeSH-major] Carcinoma, Bronchogenic / etiology. Carcinoma, Non-Small-Cell Lung / etiology. Lung Neoplasms / etiology. Lung Transplantation / adverse effects

  • Genetic Alliance. consumer health - Transplantation.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Lung Transplantation.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Heart Lung Transplant. 1998 Oct;17(10):1029-33 [9811413.001]
  • [Cites] J Heart Lung Transplant. 2001 Oct;20(10):1044-53 [11595559.001]
  • [Cites] Chest. 1995 May;107(5):1317-22 [7750325.001]
  • [Cites] Immunobiology. 1989 Feb;178(4-5):401-15 [2785485.001]
  • [Cites] Chest. 2004 Jan;125(1):165-72 [14718437.001]
  • [Cites] J Natl Cancer Inst. 2003 Mar 19;95(6):470-8 [12644540.001]
  • [Cites] Radiology. 2002 Jul;224(1):131-8 [12091672.001]
  • [Cites] Ann Transplant. 2000;5(3):13-9 [11147024.001]
  • [Cites] J Thorac Imaging. 2000 Jul;15(3):173-9 [10928609.001]
  • [Cites] Transplantation. 2005 Oct 15;80(2 Suppl):S254-64 [16251858.001]
  • [Cites] J Heart Lung Transplant. 2005 Aug;24(8):956-67 [16102428.001]
  • [Cites] Br Med J. 1950 Sep 30;2(4682):739-48 [14772469.001]
  • [Cites] Nature. 1999 Feb 11;397(6719):530-4 [10028970.001]
  • (PMID = 17097492.001).
  • [ISSN] 1557-3117
  • [Journal-full-title] The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
  • [ISO-abbreviation] J. Heart Lung Transplant.
  • [Language] eng
  • [Grant] United States / NHLBI NIH HHS / HL / K23 HL069978
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS477909; NLM/ PMC3693444
  •  go-up   go-down


61. Türüt H, Tastepe I, Kaya S, Sirmali M, Gezer S, Oz G, Findik G, Cetin G: Surgical results and prognosis of patients with primary bronchogenic carcinoma aged less than 36 years. Respirology; 2007 Sep;12(5):707-11
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Surgical results and prognosis of patients with primary bronchogenic carcinoma aged less than 36 years.
  • BACKGROUND AND OBJECTIVE: This study reports on the demographic features, clinico-pathological results and prognoses of patients aged less than 36 years diagnosed with non-small cell lung cancer (NSCLC).
  • METHODS: This is an observational study of patients with primary NSCLC who had a surgical procedure at a tertiary thoracic surgery centre in Turkey.
  • Data collected were age, gender, history of smoking, symptoms, postoperative histopathological diagnosis, stage, surgical procedure and survival.
  • Histopathological diagnosis was squamous cell carcinoma (SCC, n = 17), adenocarcinoma (n = 12), lymphoepithelioma-like carcinoma (n = 1) and undifferentiated carcinoma (n = 1).
  • Aggressive multimodality treatment may achieve satisfactory 2- and 5-year survival rates in young patients with NSCLC who usually present with advanced disease.
  • [MeSH-major] Adenocarcinoma / surgery. Carcinoma, Bronchogenic / surgery. Carcinoma, Squamous Cell / surgery
  • [MeSH-minor] Adolescent. Adult. Child. Female. Humans. Male. Neoplasm Staging. Prognosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17875059.001).
  • [ISSN] 1323-7799
  • [Journal-full-title] Respirology (Carlton, Vic.)
  • [ISO-abbreviation] Respirology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


62. Kono T, Lee S, Nohara J, Sakaguchi Y, Noguchi T, Terada Y: [A case of bronchogenic carcinoma which obtained long-term relapse free survival by argon plasma coagulation]. Nihon Kokyuki Gakkai Zasshi; 2009 Dec;47(12):1093-7
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of bronchogenic carcinoma which obtained long-term relapse free survival by argon plasma coagulation].
  • A chest X-ray and CT revealed no abnormal findings, but bronchoscopy revealed a squamous cell carcinoma nodular lesion in the bifurcation between the left B(1+2)a and B(1+2)b.
  • Another nodular squamous cell carcinoma grew in the orifice of the left B(1+2) nine months later, but this time chemotherapy was ineffective.
  • [MeSH-major] Carcinoma, Bronchogenic / surgery. Carcinoma, Squamous Cell / surgery. Laser Coagulation. Lasers, Gas / therapeutic use. Lung Neoplasms / surgery
  • [MeSH-minor] Aged. Disease-Free Survival. Humans. Male

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20058685.001).
  • [ISSN] 1343-3490
  • [Journal-full-title] Nihon Kokyūki Gakkai zasshi = the journal of the Japanese Respiratory Society
  • [ISO-abbreviation] Nihon Kokyuki Gakkai Zasshi
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


63. Shen Q, Yao Y, Teng X, Zhou J: Endobronchial metastasis from prostate cancer mimicking primary lung cancer. Intern Med; 2010;49(15):1613-5
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endobronchial metastasis from prostate cancer mimicking primary lung cancer.
  • Endobronchial metastasis from prostate cancer is a rare neoplasm which metastasizes to the proximal central or subsegmental bronchus, in a bronchoscopically visible range.
  • We present a 72-year-old man with a left superior lobar bronchus mass, intrapulmonary metastases, and bone metastases, mimicking primary lung bronchogenic carcinoma.
  • Increasing tPSA, decreasing fPSA/tPSA level, and prostatic puncture pathology proved prostate cancer.
  • Pathomorphology and immunohistochemistry of the mucosa specimen with P504S, PSA revealed the diagnosis of pulmonary metastases from prostate cancer.
  • He was in remission thirteen months after diagnosis.
  • [MeSH-major] Bronchial Neoplasms / diagnosis. Bronchial Neoplasms / secondary. Prostatic Neoplasms / diagnosis
  • [MeSH-minor] Aged. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Diagnosis, Differential. Follow-Up Studies. Humans. Lung Neoplasms / diagnosis. Lung Neoplasms / drug therapy. Lung Neoplasms / secondary. Male


64. Abuzetun JY, Hazin R, Suker M, Silberstein P: Primary squamous cell carcinoma of the lung with bony metastasis in a 13-year-old boy: case report and review of literature. J Pediatr Hematol Oncol; 2008 Aug;30(8):635-7
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary squamous cell carcinoma of the lung with bony metastasis in a 13-year-old boy: case report and review of literature.
  • Primary bronchogenic carcinoma of the lung is extremely rare in children, particularly the squamous cell type.
  • We are reporting a case of metastatic squamous cell carcinoma in a 13-year-old boy who presented with left shoulder pain secondary to bone metastasis.
  • Given the lack of specific symptoms associated with such malignancies, many children are at risk of delayed diagnosis and, as a result, associated metastases.
  • [MeSH-major] Bone Neoplasms / secondary. Carcinoma, Squamous Cell / secondary. Lung Neoplasms / pathology

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18799946.001).
  • [ISSN] 1536-3678
  • [Journal-full-title] Journal of pediatric hematology/oncology
  • [ISO-abbreviation] J. Pediatr. Hematol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


65. Uong IZ, Uong E, Ksia TI, Kakhkhorov ZhN, Razakov AP: [Clinical treatment outcome of grade III, non-small cell bronchogenic carcinoma using "whole-body" gamma-knife system]. Vopr Onkol; 2010;56(1):55-7
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Clinical treatment outcome of grade III, non-small cell bronchogenic carcinoma using "whole-body" gamma-knife system].
  • The results of treatment of 80 patients with non-small cell lung cancer using the Chinese-made "Whole-Body" gamma-knife system were analyzed.
  • Primary focus and involved lymph nodes were exposed.
  • Neither gap between primary focus and involved lymph node or nodes, nor organs of the mediastinum were exposed.
  • Exposure regimens were: STD = 4 Gy (2.5 - 10 Gy) 5 times a week; TTD=48 Gy (27-52 Gy) per primary focus and 4 Gy (3-6 Gy) 5 times a week; TTD = 43.5 Gy (30-52 Gy) per lymph nodes (105.6 - 150 Gy = equ.).
  • [MeSH-major] Carcinoma, Bronchogenic / radiotherapy. Carcinoma, Non-Small-Cell Lung / radiotherapy. Gamma Rays / therapeutic use. Lung Neoplasms / radiotherapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20361616.001).
  • [ISSN] 0507-3758
  • [Journal-full-title] Voprosy onkologii
  • [ISO-abbreviation] Vopr Onkol
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


66. Kanne JP, Bilawich AM, Lee CH, Im JG, Müller NL: Smoking-related emphysema and interstitial lung diseases. J Thorac Imaging; 2007 Aug;22(3):286-91
MedlinePlus Health Information. consumer health - Smoking.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Smoking-related emphysema and interstitial lung diseases.
  • The most common and most well-known smoking-related illnesses include chronic obstructive pulmonary disease, bronchogenic carcinoma, and ischemic heart disease.
  • However, the role of cigarette smoking in the pathogenesis of other lung diseases is becoming increasingly apparent.
  • Knowledge of both the histologic and radiographic manifestations of smoking-related lung disease is important to the radiologist as imaging findings can be nonspecific.
  • Finally, correlation of imaging and clinical information may obviate the need for open lung biopsy.
  • [MeSH-major] Lung Diseases, Interstitial / etiology. Lung Diseases, Interstitial / radiography. Pulmonary Emphysema / etiology. Pulmonary Emphysema / radiography. Smoking / adverse effects. Tomography, X-Ray Computed / methods

  • Genetic Alliance. consumer health - Emphysema.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - Interstitial Lung Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] J Thorac Imaging. 2008 May;23(2):144. Lee, Chan Hyung [corrected to Lee, Chang Hyun]
  • (PMID = 17721346.001).
  • [ISSN] 0883-5993
  • [Journal-full-title] Journal of thoracic imaging
  • [ISO-abbreviation] J Thorac Imaging
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 11
  •  go-up   go-down


67. Harr MW, Graves TG, Crawford EL, Warner KA, Reed CA, Willey JC: Variation in transcriptional regulation of cyclin dependent kinase inhibitor p21waf1/cip1 among human bronchogenic carcinomas. Mol Cancer; 2005;4:23
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Variation in transcriptional regulation of cyclin dependent kinase inhibitor p21waf1/cip1 among human bronchogenic carcinomas.
  • Because of its central role in controlling cell proliferation, upregulation of p21 has been explored as a modality for treating bronchogenic carcinoma (BC).
  • Improved understanding of p21 transcriptional regulation will facilitate identification of BC tissues that are responsive to p21-directed therapies.
  • RESULTS: Among BC samples (N = 21) p21 transcript abundance (TA) levels varied over two orders of magnitude with values ranging from 400 to 120,000 (in units of molecules/106 molecules beta-actin).
  • The p21 values in many BC were high compared to those observed in normal bronchial epithelial cells (BEC) (N = 18).
  • Among all BC samples, there was no correlation between E2F1 and p21 TA but there was positive correlation between E2F1 and p73alpha (p < 0.001) TA.
  • Among BC cell lines with inactivated p53 and wild type p73 (N = 7) there was positive correlation between p73alpha and p21 TA (p < 0.05).
  • Additionally, in a BC cell line in which both p53 and p73 were inactivated (H1155), E2F1 TA level was high (50,000), but p21 TA level was low (470).
  • Transiently expressed exogenous p73alpha in the BC cell line Calu-1, was associated with a significant (p < 0.05) 90% increase in p21 TA and a 20% reduction in E2F1 TA. siRNA mediated reduction of p73 TA in the N417 BC cell line was associated with a significant reduction in p21 TA level (p < 0.01).
  • CONCLUSION: p21 TA levels vary considerably among BC patients which may be attributable to 1) genetic alterations in Rb and p53 and 2) variation in TA levels of upstream transcription factors E2F1 and p73.
  • Here we provide evidence that p73 upregulates p21 TA in BC tissues and upregulated p21 TA may result from E2F1 upregulation of p73 but not from E2F1 directly.
  • [MeSH-major] Carcinoma, Bronchogenic / genetics. Cyclin-Dependent Kinase Inhibitor p21 / genetics. Gene Expression Regulation, Neoplastic / genetics. Transcription, Genetic / genetics

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Res. 2001 Oct 1;61(19):7052-5 [11585734.001]
  • [Cites] Semin Oncol. 2001 Apr;28(2 Suppl 4):3-13 [11479891.001]
  • [Cites] Trends Genet. 2002 Feb;18(2):90-5 [11818141.001]
  • [Cites] Hum Mutat. 2002 Jun;19(6):607-14 [12007217.001]
  • [Cites] Oncogene. 2002 Jul 18;21(31):4715-27 [12101410.001]
  • [Cites] Curr Opin Cell Biol. 2002 Dec;14(6):684-91 [12473340.001]
  • [Cites] J Mol Diagn. 2003 Aug;5(3):176-83 [12876208.001]
  • [Cites] Cancer Sci. 2003 Aug;94(8):718-24 [12901798.001]
  • [Cites] Science. 2004 Feb 6;303(5659):844-8 [14704432.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):1892-7 [14769924.001]
  • [Cites] Differentiation. 1984;25(3):229-37 [6698333.001]
  • [Cites] Cancer Res. 1984 Nov;44(11):5124-6 [6488172.001]
  • [Cites] Cell. 1986 Apr 25;45(2):219-28 [2938741.001]
  • [Cites] Princess Takamatsu Symp. 1986;17:109-22 [3332004.001]
  • [Cites] Science. 1989 Nov 3;246(4930):603-8 [2683075.001]
  • [Cites] Cell. 1991 Jun 14;65(6):1053-61 [1828392.001]
  • [Cites] Genes Dev. 1993 Mar;7(3):331-42 [8449399.001]
  • [Cites] Nucleic Acids Res. 1993 Feb 25;21(4):1047 [8451177.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3685-9 [8386381.001]
  • [Cites] Cell. 1993 May 7;73(3):487-97 [8343202.001]
  • [Cites] Cell. 1993 Nov 19;75(4):805-16 [8242751.001]
  • [Cites] Cell. 1993 Nov 19;75(4):817-25 [8242752.001]
  • [Cites] Mol Cell Biol. 1993 Dec;13(12):7813-25 [8246996.001]
  • [Cites] Nature. 1993 Dec 16;366(6456):701-4 [8259214.001]
  • [Cites] Cell. 1995 May 5;81(3):323-30 [7736585.001]
  • [Cites] Mol Cell Biol. 1995 Aug;15(8):4215-24 [7623816.001]
  • [Cites] Leukemia. 1995 Sep;9(9):1499-507 [7658719.001]
  • [Cites] Cancer Res. 1995 Nov 15;55(22):5187-90 [7585571.001]
  • [Cites] Curr Opin Cell Biol. 1995 Dec;7(6):835-42 [8608014.001]
  • [Cites] Nature. 1997 Sep 11;389(6647):191-4 [9296498.001]
  • [Cites] Oncogene. 1998 Mar 26;16(12):1513-23 [9569018.001]
  • [Cites] Am J Respir Cell Mol Biol. 1998 Jul;19(1):6-17 [9651175.001]
  • [Cites] Am J Respir Cell Mol Biol. 1998 Jul;19(1):18-24 [9651176.001]
  • [Cites] Genes Dev. 1998 Aug 1;12(15):2424-33 [9694806.001]
  • [Cites] Nature. 1998 Sep 10;395(6698):124-5 [9744267.001]
  • [Cites] Cancer Res. 1998 Nov 15;58(22):5061-5 [9823311.001]
  • [Cites] Oncogene. 1999 Jun 3;18(22):3415-21 [10362363.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2229-34 [10688915.001]
  • [Cites] Nature. 2000 Mar 2;404(6773):99-103 [10716451.001]
  • [Cites] Cancer Res. 2000 Mar 15;60(6):1609-18 [10749130.001]
  • [Cites] Nat Genet. 2000 Dec;26(4):464-9 [11101847.001]
  • [Cites] Cancer Res. 2001 Jul 15;61(14):5636-43 [11454718.001]
  • [Cites] Mol Diagn. 2001 Dec;6(4):217-25 [11774186.001]
  • (PMID = 16014176.001).
  • [ISSN] 1476-4598
  • [Journal-full-title] Molecular cancer
  • [ISO-abbreviation] Mol. Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / CDKN1A protein, human; 0 / Cyclin-Dependent Kinase Inhibitor p21; 0 / DNA-Binding Proteins; 0 / E2F1 Transcription Factor; 0 / E2F1 protein, human; 0 / Nuclear Proteins; 0 / RNA, Small Interfering; 0 / Tumor Suppressor Protein p53; 0 / Tumor Suppressor Proteins; 0 / tumor suppressor protein p73
  • [Other-IDs] NLM/ PMC1185562
  •  go-up   go-down


68. Llombart M, Chiner E, Signes-Costa J, Arriero JM, Gómez-Merino E, Andreu A, Pastor E, Ortiz de la Tabla V: [Thoracic actinomycosis: an old disorder with new clinical manifestations]. An Med Interna; 2005 Mar;22(3):124-9
MedlinePlus Health Information. consumer health - Lung Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Three cases of thoracic actinomycosis are described, two associated to bronchial obstruction (foreign body and bronchogenic carcinoma) and one in a patient with empyema.
  • [MeSH-major] Actinomycosis / diagnosis. Lung Diseases / microbiology

  • Genetic Alliance. consumer health - Anaerobic Actinomyces Infection.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15839821.001).
  • [ISSN] 0212-7199
  • [Journal-full-title] Anales de medicina interna (Madrid, Spain : 1984)
  • [ISO-abbreviation] An Med Interna
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Spain
  • [Number-of-references] 38
  •  go-up   go-down


69. Zimmermann S, Pistner W, Uebis R, Freund M: [Relevant secondary findings in magnetic resonance imaging of the heart using the examples of a bronchial carcinoma and a malignant lymphoma]. Radiologe; 2007 Oct;47(10):915-8
MedlinePlus Health Information. consumer health - MRI Scans.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Relevant secondary findings in magnetic resonance imaging of the heart using the examples of a bronchial carcinoma and a malignant lymphoma].
  • [Transliterated title] Relevante Nebenbefunde in der Magnetresonanztomographie des Herzens am Beispiel eines Bronchialkarzinoms und eines malignen Lymphoms.
  • RESULTS: A total of 53 extracardiac findings were detected: 1 lymphoma, 1 bronchogenic carcinoma, 1 retroperitoneal hematoma, 1 mediastinal lymphadenopathy, 1 tumor of the adrenal glad, 16 pleural effusions, 14 renal cysts, 12 liver cysts, 2 pulmonary infiltrate, 1 atelectasis, 2 cholecystolithiasis, 1 diaphragmatic elevation, 1 hiatus hernia.
  • [MeSH-major] Bronchial Neoplasms / diagnosis. Bronchial Neoplasms / epidemiology. Heart Diseases / diagnosis. Heart Diseases / epidemiology. Lymphoma / diagnosis. Lymphoma / epidemiology. Magnetic Resonance Imaging / statistics & numerical data


70. Ghosh SK, Roland NJ, Kumar A, Tandon S, Lancaster JL, Jackson SR, Jones A, Lewis Jones H, Hanlon R, Jones TM: Detection of synchronous lung tumors in patients presenting with squamous cell carcinoma of the head and neck. Head Neck; 2009 Dec;31(12):1563-70
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Detection of synchronous lung tumors in patients presenting with squamous cell carcinoma of the head and neck.
  • BACKGROUND: Screening for synchronous pulmonary tumors in patients presenting with squamous cell carcinoma of the head and neck (SCCHN) is important, because detection may alter subsequent management.
  • The number needed to scan, ie, the number of thoracic CTs required to detect 1 pulmonary tumor, is reported for recurrent primary tumors, primary disease load (T and N classification), and individual primary sites.
  • The incidence of pulmonary metastases is related to locoregional disease load while the incidence of bronchogenic carcinoma is sporadic.
  • CONCLUSION: Although it is possible to propose a pragmatic screening protocol for pulmonary metastases, this is not possible for bronchogenic carcinomas.
  • [MeSH-major] Carcinoma, Squamous Cell / secondary. Head and Neck Neoplasms / pathology. Lung Neoplasms / radiography. Lung Neoplasms / secondary. Mass Screening / methods. Neoplasms, Multiple Primary / radiography
  • [MeSH-minor] Adolescent. Adult. Age Distribution. Aged. Aged, 80 and over. Cohort Studies. Female. Humans. Incidence. Male. Middle Aged. Neoplasm Staging. Prognosis. Radiography, Thoracic / methods. Retrospective Studies. Risk Assessment. Sex Distribution. Survival Analysis. Tomography, X-Ray Computed / methods. Young Adult


71. Hoxworth JM, Hanks DK, Araoz PA, Elicker BM, Reddy GP, Webb WR, Leung JW, Gotway MB: Lymphoepithelioma-like carcinoma of the lung: radiologic features of an uncommon primary pulmonary neoplasm. AJR Am J Roentgenol; 2006 May;186(5):1294-9
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lymphoepithelioma-like carcinoma of the lung: radiologic features of an uncommon primary pulmonary neoplasm.
  • OBJECTIVE: The purpose of this study was to review the chest radiographic, CT, and MRI appearances of primary pulmonary lymphoepithelioma-like carcinoma (LELC).
  • CONCLUSION: Primary pulmonary LELC is histopathologically identical to nasopharyngeal carcinoma.
  • The radiographic, CT, and MRI features of primary pulmonary LELC are nonspecific, often resembling those of bronchogenic carcinoma.
  • Primary pulmonary LELC usually presents as a poorly circumscribed, enhancing, peripheral solitary pulmonary nodule on CT; necrosis may be present and is considered a poor prognostic sign.
  • Most patients present with early-stage disease.
  • Primary pulmonary LELC should be suspected in selected patients and requires differentiation from bronchogenic carcinoma and metastatic nasopharyngeal carcinoma.
  • [MeSH-major] Carcinoma / diagnosis. Lung Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16632721.001).
  • [ISSN] 1546-3141
  • [Journal-full-title] AJR. American journal of roentgenology
  • [ISO-abbreviation] AJR Am J Roentgenol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 25
  •  go-up   go-down


72. Biswas D, Agarwal S, Sindhwani G, Rawat J: Fungal colonization in patients with chronic respiratory diseases from Himalayan region of India. Ann Clin Microbiol Antimicrob; 2010;9:28
MedlinePlus Health Information. consumer health - Yeast Infections.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: The major diagnostic groups included patients with bronchogenic carcinoma (n = 31) and tubercular sequelae (n = 16).
  • Patients with bronchogenic carcinoma showed increased predilection for colonisation with Aspergillus, while Candida was recovered more commonly in tubercular sequelae (p = 0.02).
  • An interesting predilection was observed for Aspergillus and Candida, to preferentially infect patients with Bronchogenic carcinoma and Tubercular sequelae respectively.
  • [MeSH-major] Aspergillus / growth & development. Candida / growth & development. Candidiasis / diagnosis. Lung / microbiology. Lung Diseases, Fungal / diagnosis. Pulmonary Aspergillosis / diagnosis. Respiratory Tract Diseases / complications
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Antibodies, Fungal / analysis. Bronchoalveolar Lavage Fluid / microbiology. Carcinoma, Bronchogenic / complications. Carcinoma, Bronchogenic / microbiology. Cohort Studies. Female. Humans. India. Lung Neoplasms / complications. Lung Neoplasms / microbiology. Male. Middle Aged. Tuberculosis / complications. Tuberculosis / microbiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Indian J Pathol Microbiol. 2003 Jul;46(3):507-10 [15025326.001]
  • [Cites] Chest. 2001 Jul;120(1):177-84 [11451835.001]
  • [Cites] Thorax. 1983 Aug;38(8):572-8 [6612647.001]
  • [Cites] Eur J Clin Microbiol Infect Dis. 1990 May;9(5):352-5 [2373089.001]
  • [Cites] Bone Marrow Transplant. 1993 Aug;12(2):121-4 [8401356.001]
  • [Cites] Mycopathologia. 1994 Apr;126(1):3-7 [8052291.001]
  • [Cites] Med Clin North Am. 1994 Sep;78(5):1049-65 [8078368.001]
  • [Cites] Eur J Clin Microbiol Infect Dis. 1994 Aug;13(8):665-7 [7813500.001]
  • [Cites] Eur J Clin Microbiol Infect Dis. 1994 Sep;13(9):756-60 [7843181.001]
  • [Cites] Chest. 1997 Feb;111(2):411-8 [9041990.001]
  • [Cites] Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):583-90 [9279244.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2006 Feb;132(2):173-8 [16490875.001]
  • [Cites] Clin Infect Dis. 2008 Jun 15;46(12):1813-21 [18462102.001]
  • [Cites] Indian J Med Sci. 2000 Nov;54(11):491-4 [11354809.001]
  • [Cites] Indian J Pathol Microbiol. 1977 Apr;20(2):101-4 [415973.001]
  • (PMID = 20854652.001).
  • [ISSN] 1476-0711
  • [Journal-full-title] Annals of clinical microbiology and antimicrobials
  • [ISO-abbreviation] Ann. Clin. Microbiol. Antimicrob.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antibodies, Fungal
  • [Other-IDs] NLM/ PMC2949792
  •  go-up   go-down


73. Ernam D, Atalay F, Hasanoglu HC, Kaplan O: Role of biochemical tests in the diagnosis of exudative pleural effusions. Clin Biochem; 2005 Jan;38(1):19-23

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Role of biochemical tests in the diagnosis of exudative pleural effusions.
  • OBJECTIVES: To examine the diagnostic utility of pleural adenosine deaminase (PADA), pleural lactate dehydrogenase (PLDH), and several other biochemical tests in bronchogenic carcinoma and malignant mesothelioma, and to compare biochemical characteristics of their fluid with nonmalignant pleural effusions.
  • DESIGN AND METHODS: This study consisted of 226 patients diagnosed with malignant (75), tuberculous (65), and parapneumonic pleural effusions (86).
  • RESULTS: Parapneumonic pleural effusions had a significantly higher level of PLDH and of P/S LDH than malignant and tuberculous pleural effusions (P = 0.000), and malignant pleural effusions had a higher level of PLDH than tuberculous pleural effusions.
  • Tuberculous and parapneumonic effusions had significantly higher levels of PADA than those of malignant effusions (P = 0.000).
  • When the 54 patients having bronchogenic carcinoma were compared to the remaining 21 mesothelioma patients, the former had a lower median level of PADA (P = 0.001) with a higher level of PLDH (P = 0.05).
  • CONCLUSION: Our results show that high pleural LDH and low PADA levels are suggestive of pleural effusion due to bronchogenic carcinoma, whereas high levels of PADA alone can be indicative of tuberculous pleural effusion and high levels of both markers can show complicated parapneumonic effusions or empyema.
  • [MeSH-major] Adenosine Deaminase. L-Lactate Dehydrogenase. Pleural Effusion / diagnosis
  • [MeSH-minor] Carcinoma, Bronchogenic / diagnosis. Female. Humans. Male. Mesothelioma / diagnosis. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15607312.001).
  • [ISSN] 0009-9120
  • [Journal-full-title] Clinical biochemistry
  • [ISO-abbreviation] Clin. Biochem.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] EC 1.1.1.27 / L-Lactate Dehydrogenase; EC 3.5.4.4 / Adenosine Deaminase
  •  go-up   go-down


74. Kim AW, Liptay MJ, Saclarides TJ, Warren WH: Endobronchial colorectal metastasis versus primary lung cancer: a tale of two sleeve right upper lobectomies. Interact Cardiovasc Thorac Surg; 2009 Aug;9(2):379-81
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endobronchial colorectal metastasis versus primary lung cancer: a tale of two sleeve right upper lobectomies.
  • Endobronchial metastasis from colorectal carcinoma is relatively uncommon whereas primary bronchogenic carcinoma is more common.
  • These two disease entities can both appear to be similar clinically and radiographically.
  • Palliative treatment rather than a curative-intent anatomic resection is typically employed in the setting of endobronchial metastatic disease.
  • We compare two cases of patients with a history of colorectal carcinoma with endobronchial lesions of which one was truly a metastatic lesion.
  • [MeSH-major] Adenocarcinoma / surgery. Carcinoma, Non-Small-Cell Lung / surgery. Colorectal Neoplasms / pathology. Lung Neoplasms / surgery. Pneumonectomy
  • [MeSH-minor] Diagnosis, Differential. Humans. Lymph Node Excision. Male. Middle Aged. Neoplasm Staging. Tomography, X-Ray Computed. Treatment Outcome


75. Paramez AR, Dixit R, Gupta N, Gupta R, Arya M: Non-small cell lung carcinoma presenting as carcinomatous meningitis. Lung India; 2010 Jul;27(3):158-60

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Non-small cell lung carcinoma presenting as carcinomatous meningitis.
  • Meningeal carcinomatosis is a diffuse infiltration of leptomeninges and sub arachnoid space by malignant cells metastasizing from systemic cancer.
  • Primary bronchogenic carcinoma presenting as carcinomatous meningitis is a very rare occurrence in clinical practice, often occurring during the treatment course of the underlying malignancy.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20931036.001).
  • [ISSN] 0974-598X
  • [Journal-full-title] Lung India : official organ of Indian Chest Society
  • [ISO-abbreviation] Lung India
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC2946719
  • [Keywords] NOTNLM ; Adenocarcinoma lung / carcinomatous meningitis / malignant metastasis
  •  go-up   go-down


76. Jamnik S, Uehara C, da Silva VV: Location of lung carcinoma in relation to the smoking habit and gender. J Bras Pneumol; 2006 Nov-Dec;32(6):510-4
MedlinePlus Health Information. consumer health - Smoking.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Location of lung carcinoma in relation to the smoking habit and gender.
  • OBJECTIVE: To analyze the locations of lung carcinomas in relation to patient gender and smoking status.
  • METHODS: In order to test the hypothesis that lung carcinoma location (upper or lower lobe; left or right side) is correlated with smoking status and gender, we conducted a retrospective study of 697 patients with bronchogenic carcinoma treated at the Pulmonology-Oncology Outpatient Clinic of the Federal University of São Paulo.
  • RESULTS: We found that the bronchogenic carcinomas occurring in smokers were more frequently located in the upper lobes, whereas those occurring in nonsmokers were more frequently located in the lower lobes.
  • CONCLUSION: Overall, bronchogenic carcinomas are predominantly found in the upper lobes.
  • In females, bronchogenic carcinomas present a tendency to occur more often in the lower lobes.
  • [MeSH-major] Carcinoma, Bronchogenic / pathology. Lung Neoplasms / etiology. Lung Neoplasms / pathology. Smoking / adverse effects

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17435901.001).
  • [ISSN] 1806-3756
  • [Journal-full-title] Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia
  • [ISO-abbreviation] J Bras Pneumol
  • [Language] eng; por
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


77. Lindenmann J, Matzi V, Maier A, Smolle-Juettner FM: Transthoracic esophagectomy and lobectomy performed in a patient with synchronous lung cancer and combined esophageal cancer and esophageal leiomyosarcoma. Eur J Cardiothorac Surg; 2007 Feb;31(2):322-4
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Transthoracic esophagectomy and lobectomy performed in a patient with synchronous lung cancer and combined esophageal cancer and esophageal leiomyosarcoma.
  • We report a pitfall deriving from the assumption of metastatic disease based upon seemingly identical histology in a pulmonary lesion and in the esophagus.
  • In a 60-year-old patient, cT1 esophageal squamous cell carcinoma was found.
  • Definitive histology showed pT1N0 cancer of the esophagus, primary esophageal sarcoma and pT4N0 bronchogenic carcinoma.
  • The other pulmonary lesion was re-evaluated and defined as intralobar M1 of bronchogenic carcinoma.
  • [MeSH-major] Carcinoma, Squamous Cell / secondary. Esophageal Neoplasms / diagnosis. Leiomyosarcoma / diagnosis. Lung Neoplasms / secondary. Neoplasms, Multiple Primary / diagnosis
  • [MeSH-minor] Carcinoma, Bronchogenic / diagnosis. Diagnosis, Differential. Esophagectomy. Humans. Male. Middle Aged. Palliative Care. Pneumonectomy


78. Herrmann T: Radiation oncology and functional imaging. Nuklearmedizin; 2005;44 Suppl 1:S38-40

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PET/CT imaging is most likely to be of use in radiation oncology with patients who have poorly defined target volume areas, e.g. brain tumours, bronchogenic carcinoma, and cases of miscellaneous geographical miss.
  • Other tumours that call for dose escalated radiotherapy, such as head and neck tumours, bronchogenic carcinoma, and prostate carcinomas may further benefit from an accurate delineation of the metabolically active tumour volume and its differentiation from surrounding healthy tissue, or tumour atelectosis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16395977.001).
  • [ISSN] 0029-5566
  • [Journal-full-title] Nuklearmedizin. Nuclear medicine
  • [ISO-abbreviation] Nuklearmedizin
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


79. Wang GF, Lai MD, Chen PH: [Correlation of multiple primary lung cancer with bronchial and alveolar epithelial dysplasia]. Zhejiang Da Xue Xue Bao Yi Xue Ban; 2005 Sep;34(5):427-31
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Correlation of multiple primary lung cancer with bronchial and alveolar epithelial dysplasia].
  • OBJECTIVE: To investigate the correlation of multiple primary lung cancer with bronchial epithelial dysplasia and atypical adenomatous hyperplasia of bronchiolo-alveolar epithelium.
  • METHODS: Careful pathological examinations were performed on 114 surgical specimens of primary lung carcinoma.
  • The correlation of multiple primary lung cancer with bronchial epithelial dysplasia and atypical adenomatous hyperplasia of bronchiolo-alveolar epithelium was analyzed.
  • RESULTS: Of 114 cases of primary lung cancer,13 cases of multiple primary lung cancer (11.4 %) was identifiedìwhich consisted of 6 cases containing two primary bronchogenic carcinoma and 7 containing one bronchogenic carcinoma and one bronchiolo-alveolar carcinoma.
  • The rate of multiple primary lung cancers was significantly higher in individuals with high grade bronchial epithelial dysplasia than in those with low grade dysplasia (r=0.238, P<0.05).
  • CONCLUSION: Bronchial and alveolar epithelial cells may develop malignancy synchronously or metachronously.
  • The probability of developing multiple primary lung cancer will increase in the lungs with extensive and severe bronchial epithelial dysplasia.
  • [MeSH-major] Bronchi / pathology. Carcinoma, Squamous Cell / pathology. Lung Neoplasms / pathology. Neoplasms, Multiple Primary / pathology. Pulmonary Alveoli / pathology
  • [MeSH-minor] Adenocarcinoma / pathology. Adult. Aged. Carcinoma, Small Cell / pathology. Cell Proliferation. Female. Humans. Hyperplasia. Male. Middle Aged. Precancerous Conditions / pathology. Respiratory Mucosa / pathology

  • Genetic Alliance. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16216054.001).
  • [ISSN] 1008-9292
  • [Journal-full-title] Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
  • [ISO-abbreviation] Zhejiang Da Xue Xue Bao Yi Xue Ban
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


80. Freixinet JL, Julià-Serdà G, Rodríguez PM, Santana NB, de Castro FR, Fiuza MD, López-Encuentra A, Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery GCCB-S: Hospital volume: operative morbidity, mortality and survival in thoracotomy for lung cancer. A Spanish multicenter study of 2994 cases. Eur J Cardiothorac Surg; 2006 Jan;29(1):20-5
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hospital volume: operative morbidity, mortality and survival in thoracotomy for lung cancer. A Spanish multicenter study of 2994 cases.
  • OBJECTIVE: To determine the relationship between the number of interventions and the operative morbidity, mortality and long-term survival in the surgery of bronchogenic carcinoma (BC).
  • PATIENTS AND METHOD: Prospective, multicenter Spanish study was conducted in 19 departments of thoracic surgery on 2994 patients operated on consecutively with the aim of curing BC.
  • [MeSH-major] Carcinoma, Bronchogenic / epidemiology. Lung Neoplasms / epidemiology. Thoracotomy / mortality

  • Genetic Alliance. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16343923.001).
  • [ISSN] 1010-7940
  • [Journal-full-title] European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
  • [ISO-abbreviation] Eur J Cardiothorac Surg
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  •  go-up   go-down


81. de Perrot M, Fadel E, Mercier O, Mussot S, Chapelier A, Dartevelle P: Long-term results after carinal resection for carcinoma: does the benefit warrant the risk? J Thorac Cardiovasc Surg; 2006 Jan;131(1):81-9
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Long-term results after carinal resection for carcinoma: does the benefit warrant the risk?
  • OBJECTIVE: We sought to determine whether the benefit warrants the risk in patients undergoing carinal resection for carcinoma.
  • RESULTS: Between June 1981 and August 2004, 119 patients underwent carinal resection for carcinoma in our institution.
  • Superior vena caval resection was combined with carinal pneumonectomy in 25 patients with bronchogenic carcinoma (13 patients had complete superior vena caval resection with graft interposition).
  • The 5- and 10-year survivals were 44% and 25%, respectively, for patients with bronchogenic carcinoma (n = 100).
  • However, survival was significantly better in patients with N0 or N1 disease (n = 73) than in those with N2 or N3 disease (n = 27; 53% vs 15% at 5 years, respectively).
  • The 5- and 10-year survivals in the remaining 19 patients reached 66% and 48%, respectively, and were best in patients with neuroendocrine carcinoma (100% survival at 10 years) and adenoid cystic carcinoma (69% survival at 10 years).
  • CONCLUSIONS: Surgical intervention for carcinoma involving the carina is feasible, with acceptable mortality and good long-term survival in selected patients.
  • The presence of positive N2 disease should, however, be considered a potential contraindication to carinal resection in patients with bronchogenic carcinoma because of the poor long-term survival.
  • [MeSH-major] Lung Neoplasms / surgery. Neoplasms, Multiple Primary / surgery. Pneumonectomy / methods. Trachea / surgery. Tracheal Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16399298.001).
  • [ISSN] 1097-685X
  • [Journal-full-title] The Journal of thoracic and cardiovascular surgery
  • [ISO-abbreviation] J. Thorac. Cardiovasc. Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


82. Vereş L, Mihdescu T, Beda E: [Pulmonary thromboembolism: specifics of diagnosis in young age--case report]. Pneumologia; 2009 Jan-Mar;58(1):49-51
MedlinePlus Health Information. consumer health - Pulmonary Embolism.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Pulmonary thromboembolism: specifics of diagnosis in young age--case report].
  • [Transliterated title] Trombembolismul pulmonar: particularităţi de diagnostic la adultul tânăr--caz clinic.
  • It is considered that PTE causes pleural effusions more frequently than bronchogenic carcinoma although statistics bring it to less than 5% of diagnosed cases.
  • This probably relies in an insufficient investigation of patients with pleural effusion as well as considering PTE a rare cause of disease.
  • Our case reveals both a delay in the diagnosis as well as a genetic linkage for PTE.
  • [MeSH-major] Pulmonary Embolism / diagnosis
  • [MeSH-minor] Anti-Bacterial Agents / therapeutic use. Anticoagulants / therapeutic use. Diagnosis, Differential. Humans. Male. Pleural Effusion / diagnosis. Pleural Effusion / etiology. Pneumonia / complications. Risk Factors. Smoking / adverse effects. Treatment Outcome. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19507487.001).
  • [ISSN] 2067-2993
  • [Journal-full-title] Pneumologia (Bucharest, Romania)
  • [ISO-abbreviation] Pneumologia
  • [Language] rum
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Romania
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents; 0 / Anticoagulants
  •  go-up   go-down


83. Prabhu S, Sripathi H, Rao R, Hameed S: Thoracopulmonary actinomycosis: the masquerader. Clin Exp Dermatol; 2008 May;33(3):262-5
Hazardous Substances Data Bank. PENICILLIN V .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Thoracopulmonary actinomycosis can mimic various lung pathologies such as bronchogenic carcinoma, tuberculosis and fungal pneumonia, to name but a few.
  • The disease is successfully diagnosed only if there is a high index of suspicion and a thorough evaluation with multidisciplinary involvement.
  • [MeSH-major] Actinomycosis / diagnosis. Lung Diseases / diagnosis
  • [MeSH-minor] Adult. Anti-Bacterial Agents / administration & dosage. Diagnosis, Differential. Humans. Injections, Intravenous. Male. Penicillin G / administration & dosage. Penicillin V / administration & dosage. Prognosis. Tomography, X-Ray Computed. Treatment Outcome. Tuberculosis, Pulmonary / diagnosis

  • Genetic Alliance. consumer health - Anaerobic Actinomyces Infection.
  • MedlinePlus Health Information. consumer health - Lung Diseases.
  • Hazardous Substances Data Bank. PENICILLIN VK .
  • Hazardous Substances Data Bank. PENICILLIN G .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18076682.001).
  • [ISSN] 0307-6938
  • [Journal-full-title] Clinical and experimental dermatology
  • [ISO-abbreviation] Clin. Exp. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents; Q42T66VG0C / Penicillin G; Z61I075U2W / Penicillin V
  •  go-up   go-down


84. Shavit L, Maly B, Rosenbaum E, Grenader T: Endotracheal metastases in renal cell carcinoma: A life-threatening but treatable complication. Eur J Intern Med; 2007 Mar;18(2):161-3

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endotracheal metastases in renal cell carcinoma: A life-threatening but treatable complication.
  • Endotracheal obstruction, by primary bronchogenic carcinoma or by metastases from extrapulmonary tumors, is a rare and life-threatening complication in cancer patients.
  • We report a patient with metastatic renal cell carcinoma who developed almost complete obstruction of the trachea and who was successfully managed with bronchoscopic resection of endotracheal metastases.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17338974.001).
  • [ISSN] 0953-6205
  • [Journal-full-title] European journal of internal medicine
  • [ISO-abbreviation] Eur. J. Intern. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


85. Gaissert HA, Grillo HC, Shadmehr MB, Wright CD, Gokhale M, Wain JC, Mathisen DJ: Uncommon primary tracheal tumors. Ann Thorac Surg; 2006 Jul;82(1):268-72; discussion 272-3
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Uncommon primary tracheal tumors.
  • BACKGROUND: Primary tracheal tumors other than adenoid cystic or squamous cell carcinoma are uncommon and have a heterogeneous histologic appearance.
  • METHODS: A retrospective analysis was performed of uncommon tracheal tumors among 360 primary tracheal tumors seen over 40 years, excluding adenoid cystic and squamous cell carcinoma.
  • RESULTS: Of 90 patients, 34 (38%) had benign tumors and 56 malignant: 11 carcinoid tumors, 14 mucoepidermoid carcinomas, 13 sarcomas, 15 nonsquamous bronchogenic carcinomas, 2 lymphomas, and 1 melanoma.
  • Dyspnea was the most common symptom in benign tumors and hemoptysis in malignant tumors.
  • After resection, survival at 10 years was 94% for benign and 83% for carcinoid tumors, and at 5 years survival was 60% for bronchogenic carcinoma, 100% for mucoepidermoid tumors, and 78% for sarcomas.
  • CONCLUSIONS: Surgical resection of uncommon primary tracheal tumors alleviates airway obstruction, is curative in patients with benign or slow-growing malignant lesions, and prolongs survival in highly malignant lesions.
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Bronchi / surgery. Bronchoscopy. Child. Child, Preschool. Combined Modality Therapy. Female. Follow-Up Studies. Hospital Mortality. Humans. Laryngeal Neoplasms / epidemiology. Laryngeal Neoplasms / pathology. Laryngeal Neoplasms / surgery. Laryngectomy. Life Tables. Male. Middle Aged. Neoplasm Metastasis. Neoplasm Recurrence, Local / epidemiology. Postoperative Complications / epidemiology. Radiotherapy, Adjuvant. Reoperation. Retrospective Studies. Survival Analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16798228.001).
  • [ISSN] 1552-6259
  • [Journal-full-title] The Annals of thoracic surgery
  • [ISO-abbreviation] Ann. Thorac. Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


86. King MM, Nelson DA: Hypertrophic osteoarthropathy effectively treated with zoledronic acid. Clin Lung Cancer; 2008 May;9(3):179-82
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Hypertrophic osteoarthropathy (HOA) is a syndrome characterized by digital clubbing, arthralgias, and tissue swelling and is frequently described in association with bronchogenic carcinoma.
  • We present a patient with HOA of the lower extremities and wrists that developed after bronchogenic carcinoma.
  • [MeSH-minor] Carcinoma, Bronchogenic / complications. Female. Humans. Lung Neoplasms / complications. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18621629.001).
  • [ISSN] 1525-7304
  • [Journal-full-title] Clinical lung cancer
  • [ISO-abbreviation] Clin Lung Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Bone Density Conservation Agents; 0 / Diphosphonates; 0 / Imidazoles; 6XC1PAD3KF / zoledronic acid
  •  go-up   go-down


87. Chhajed PN, Bubendorf L, Hirsch H, Boehler A, Weder W, Tamm M: Mesothelioma after lung transplantation. Thorax; 2006 Oct;61(10):916-7
MedlinePlus Health Information. consumer health - Mesothelioma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mesothelioma after lung transplantation.
  • The case history is presented of a lung transplant recipient who developed malignant mesothelioma.
  • Mesothelioma should be suspected in lung transplant recipients with a haemorrhagic pleural effusion in the native lung when there is no convincing evidence for bronchogenic carcinoma or post transplant lymphoproliferative disease, even in the absence of exposure to asbestos.
  • [MeSH-major] Lung Transplantation / adverse effects. Mesothelioma / etiology

  • Genetic Alliance. consumer health - Transplantation.
  • MedlinePlus Health Information. consumer health - Lung Transplantation.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Heart Lung Transplant. 2002 May;21(5):547-54 [11983544.001]
  • [Cites] Radiology. 2002 Jul;224(1):131-8 [12091672.001]
  • [Cites] J Thorac Cardiovasc Surg. 2003 Jan;125(1):45-8 [12538984.001]
  • [Cites] Chest. 2004 Jan;125(1):165-72 [14718437.001]
  • [Cites] J Heart Lung Transplant. 2003 Jun;22(6):625-35 [12821160.001]
  • [Cites] Oncogene. 2003 Aug 11;22(33):5173-80 [12910254.001]
  • [Cites] J Heart Lung Transplant. 2003 Oct;22(10):1174-7 [14550828.001]
  • [Cites] Ann Thorac Surg. 2003 Feb;75(2):367-71 [12607641.001]
  • (PMID = 17008483.001).
  • [ISSN] 0040-6376
  • [Journal-full-title] Thorax
  • [ISO-abbreviation] Thorax
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2104770
  •  go-up   go-down


88. Sharma V, Sharma NL, Ranjan N, Tegta GR, Sarin S: Acrokeratosis paraneoplastica (Bazex syndrome): case report and review of literature. Dermatol Online J; 2006;12(1):11

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This syndrome is important because the cutaneous findings preceed the onset of symptoms referable to the underlying neoplasm by several months in majority of the cases.
  • We report here a case of a 63-year-old cachectic female who had classic psoriasiform lesions of acrokeratosis of Bazex with underlying bronchogenic carcinoma of the right lung.
  • [MeSH-minor] Carcinoma, Bronchogenic / radiography. Female. Humans. Lung Neoplasms / radiography. Lymphatic Metastasis / radiography. Middle Aged. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16638379.001).
  • [ISSN] 1087-2108
  • [Journal-full-title] Dermatology online journal
  • [ISO-abbreviation] Dermatol. Online J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 7
  •  go-up   go-down


89. Madhusudhan KS, Gamanagatti S, Seith A, Hari S: Pulmonary infections mimicking cancer: report of four cases. Singapore Med J; 2007 Dec;48(12):e327-31
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pulmonary infections mimicking cancer: report of four cases.
  • Lung infections infrequently simulate cancer, and their differentiation, based on imaging findings, can sometimes be difficult.
  • A specific diagnosis is necessary for initiation of appropriate therapy.
  • We report four cases of chronic pulmonary infections, which were wrongly diagnosed as bronchogenic carcinoma based on radiological features.
  • [MeSH-major] Actinomycosis / diagnosis. Lung Diseases, Fungal / diagnosis. Lung Neoplasms / diagnosis. Mucormycosis / diagnosis. Tuberculosis, Pulmonary / diagnosis
  • [MeSH-minor] Adult. Antifungal Agents / therapeutic use. Antitubercular Agents / therapeutic use. Diagnosis, Differential. Female. Humans. Male. Middle Aged. Respiratory Tract Infections / diagnosis. Respiratory Tract Infections / therapy. Risk Assessment. Sampling Studies. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18043829.001).
  • [ISSN] 0037-5675
  • [Journal-full-title] Singapore medical journal
  • [ISO-abbreviation] Singapore Med J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Singapore
  • [Chemical-registry-number] 0 / Antifungal Agents; 0 / Antitubercular Agents
  •  go-up   go-down


90. Kim HJ, Kim MJ, Lee MJ, Ahn JH, Kim HS, Kim IS, Lee JS, Lee GW: Coexistence of chronic myeloid leukemia and pulmonary plasmacytoma mimicking primary lung cancer. Int J Hematol; 2010 Nov;92(4):651-4
Genetic Alliance. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Coexistence of chronic myeloid leukemia and pulmonary plasmacytoma mimicking primary lung cancer.
  • A 61-year-old man was diagnosed with the simultaneous occurrence of chronic myeloid leukemia (CML) and infiltrative intrathoracic plasmacytoma, radiologically mimicking bronchogenic carcinoma.
  • [MeSH-major] Leukemia, Myeloid, Chronic-Phase / diagnosis. Neoplasms, Multiple Primary / diagnosis. Plasmacytoma / diagnosis. Thoracic Neoplasms / diagnosis
  • [MeSH-minor] Carcinoma, Bronchogenic / diagnosis. Diagnosis, Differential. Fatal Outcome. Humans. Lung Neoplasms / diagnosis. Male. Middle Aged

  • Genetic Alliance. consumer health - Chronic Myeloid Leukemia.
  • Genetic Alliance. consumer health - Leukemia, Myeloid.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20967517.001).
  • [ISSN] 1865-3774
  • [Journal-full-title] International journal of hematology
  • [ISO-abbreviation] Int. J. Hematol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


91. Gómez-Caro A, Piñero A, Roca MJ, Torres J, Ferri B, Galindo PJ, Parrilla P: Surgical treatment of solitary metastasis in the male breast from non-small cell lung cancer. Breast J; 2006 Jul-Aug;12(4):366-7
MedlinePlus Health Information. consumer health - Mastectomy.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Surgical treatment of solitary metastasis in the male breast from non-small cell lung cancer.
  • We present a case of metastases in breast tissue from surgically treated non-small cell bronchogenic carcinoma.
  • The patient is alive and disease-free 18 months after the breast surgery.
  • [MeSH-major] Breast Neoplasms / secondary. Breast Neoplasms / surgery. Carcinoma, Non-Small-Cell Lung / secondary. Carcinoma, Non-Small-Cell Lung / surgery. Lung Neoplasms / pathology. Mastectomy


92. Shamim MS, Bari ME, Enam SA: Dural metastases presenting as an extradural hematoma: a rare presentation. J Pak Med Assoc; 2005 Nov;55(11):509-10

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This patient was later found to have dural metastases secondary to bronchogenic carcinoma.
  • Dural metastases are rare, usually presenting as dural mass, but may also present as chronic subdural or extradural hematoma on non contrast CT scan, leading to an erroneous diagnosis in the unsuspecting.
  • [MeSH-major] Carcinoma, Bronchogenic / pathology. Dura Mater / pathology. Hematoma / diagnosis. Meningeal Neoplasms / secondary. Neoplasm Metastasis / pathology
  • [MeSH-minor] Aged. Diagnosis, Differential. Humans. Male. Paresis / diagnosis. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16304875.001).
  • [ISSN] 0030-9982
  • [Journal-full-title] JPMA. The Journal of the Pakistan Medical Association
  • [ISO-abbreviation] J Pak Med Assoc
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Pakistan
  •  go-up   go-down


93. Congregado M, Merchan RJ, Gallardo G, Ayarra J, Loscertales J: Video-assisted thoracic surgery (VATS) lobectomy: 13 years' experience. Surg Endosc; 2008 Aug;22(8):1852-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Major lung resection by video-assisted thoracic surgery (VATS) has been proven to be both safe and technically feasible, but is not routinely performed in most hospitals.
  • The clinical records of all patients were drawn from the hospital archive and data for the following variables were recorded for analysis: age, sex, clinical diagnosis, clinical status, date of surgery, type of surgery, inoperability, conversion to conventional surgery and reasons, duration of surgery and intraoperative complications, postoperative and long-term complications, postoperative stay, diagnosis, definitive status, and mortality.
  • RESULTS: A total of 237 major pulmonary resections were performed, on 203 males and 34 males, with a mean age of 61.43 years (non-small-cell bronchogenic carcinoma: 204, benign processes: 24, carcinoid tumors: 4, and lobectomy due to metastases: 5).
  • CONCLUSIONS: VATS lobectomy is a viable safe procedure that meets oncological criteria for lung cancer surgery.
  • In our experience, VATS is currently to be considered ideally indicated for certain benign processes and for T1-T2 N0 M0 bronchogenic carcinomas.
  • [MeSH-major] Lung / surgery. Thoracic Surgery, Video-Assisted
  • [MeSH-minor] Adolescent. Adult. Aged. Carcinoid Tumor / surgery. Carcinoma, Bronchogenic / surgery. Child. Female. Follow-Up Studies. Humans. Length of Stay. Lung Diseases / surgery. Lung Neoplasms / pathology. Lung Neoplasms / surgery. Male. Middle Aged. Neoplasm Metastasis. Neoplasm Recurrence, Local. Neoplasm Staging. Pneumonectomy / adverse effects. Retrospective Studies. Survival Analysis. Time Factors

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Semin Thorac Cardiovasc Surg. 1998 Oct;10(4):291-9 [9801250.001]
  • [Cites] Ann Thorac Surg. 2002 Mar;73(3):900-4 [11899198.001]
  • [Cites] Ann Thorac Surg. 2000 Jul;70(1):243-7 [10921716.001]
  • [Cites] Ann Ital Chir. 2000 Sep-Oct;71(5):539-43 [11217470.001]
  • [Cites] Eur J Cardiothorac Surg. 2001 Sep;20(3):455-63 [11509263.001]
  • [Cites] J Pediatr Surg. 2003 Jan;38(1):102-4 [12592629.001]
  • [Cites] Surg Today. 2003;33(1):7-12 [12560900.001]
  • [Cites] Ann Thorac Surg. 2006 Feb;81(2):421-5; discussion 425-6 [16427825.001]
  • [Cites] Ann Thorac Surg. 2001 Aug;72(2):362-5 [11515867.001]
  • [Cites] Eur J Cardiothorac Surg. 2004 Jul;26(1):158-64 [15200996.001]
  • [Cites] Eur J Cardiothorac Surg. 2006 Jun;29(6):997-1000 [16716918.001]
  • [Cites] Surg Endosc. 2003 Apr;17(4):632-5 [12582766.001]
  • [Cites] Chest. 1996 Jun;109(6):1636-42 [8769523.001]
  • [Cites] Ann Ital Chir. 2003 May-Jun;74(3):299-307 [14677287.001]
  • [Cites] Eur J Cardiothorac Surg. 2000 Jul;18(1):7-11 [10869933.001]
  • [Cites] World J Surg. 2000 Jan;24(1):27-30; discussion 30-1 [10594199.001]
  • [Cites] Eur J Cardiothorac Surg. 2006 May;29(5):806-9 [16581257.001]
  • [Cites] Semin Thorac Cardiovasc Surg. 1998 Oct;10(4):285-90 [9801249.001]
  • [Cites] Ann Thorac Surg. 2003 Oct;76(4):1009-14; discussion 1014-5 [14529976.001]
  • [Cites] Chest. 2004 Sep;126(3):725-32 [15364748.001]
  • [Cites] Surg Endosc. 2002 Jun;16(6):881-92 [12163949.001]
  • [Cites] Ann Thorac Surg. 2000 Nov;70(5):1644-6 [11093502.001]
  • [Cites] Eur J Cardiothorac Surg. 2001 Sep;20(3):437-42 [11509260.001]
  • [Cites] Thorac Cardiovasc Surg. 2006 Apr;54(3):202-7 [16639684.001]
  • [Cites] Eur J Cardiothorac Surg. 2003 Mar;23(3):397-402 [12614813.001]
  • (PMID = 18157567.001).
  • [ISSN] 1432-2218
  • [Journal-full-title] Surgical endoscopy
  • [ISO-abbreviation] Surg Endosc
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


94. Hsieh CC, Yang RS, Huang KY: Incidental solitary knee mass as the first manifestation of hidden lung cancer. Knee; 2009 Mar;16(2):161-4
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Incidental solitary knee mass as the first manifestation of hidden lung cancer.
  • Its pulmonary causes include bronchogenic carcinoma, tuberculosis, pulmonary abscess, bronchiectasis, emphysema, etc.
  • We report one case that had an incidental finding of HPOA with initial complaint about an incidental solitary knee mass with painful swelling of right knee, leading to early diagnosis of occult bronchogenic carcinoma.
  • Patient received right S2 segmentectomy of lung with pathological confirmation of adenocarcinoma of lung cancer.
  • It is important for the clinician to be aware of the radiographic findings of periostitis of HPOA, which may be the clues leading to early detection of lung cancer without significant pulmonary symptoms and to avoid possible tumor progression and distant metastases.
  • [MeSH-major] Carcinoma, Bronchogenic / diagnosis. Knee / pathology. Lung Neoplasms / diagnosis. Osteoarthropathy, Secondary Hypertrophic / diagnosis

  • Genetic Alliance. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19013072.001).
  • [ISSN] 0968-0160
  • [Journal-full-title] The Knee
  • [ISO-abbreviation] Knee
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


95. Hays LE, Zodrow DM, Yates JE, Deffebach ME, Jacoby DB, Olson SB, Pankow JF, Bagby GC: Cigarette smoke induces genetic instability in airway epithelial cells by suppressing FANCD2 expression. Br J Cancer; 2008 May 20;98(10):1653-61
SciCrunch. HGNC: Data: Gene Annotation .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Chromosomal abnormalities are commonly found in bronchogenic carcinoma cells, but the molecular causes of chromosomal instability (CIN) and their relationship to cigarette smoke has not been defined.
  • Cigarette smoke condensate also suppressed FANCD2 function and induced CIN in bronchogenic carcinoma cells, but these cells were resistant to CSC-induced apoptosis relative to normal airway epithelial cells.
  • Carcinogen-mediated suppression of FANCD2 gene expression provides a plausible molecular mechanism for CIN in bronchogenic carcinogenesis.

  • MedlinePlus Health Information. consumer health - Secondhand Smoke.
  • MedlinePlus Health Information. consumer health - Smoking.
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arch Environ Health. 1979 Jan-Feb;34(1):17-23 [434921.001]
  • [Cites] Respir Res. 2006;7:132 [17062156.001]
  • [Cites] Cell Cycle. 2004 Aug;3(8):1062-8 [15254392.001]
  • [Cites] Proc Soc Exp Biol Med. 1969 May;131(1):247-50 [5770113.001]
  • [Cites] Arch Environ Health. 1979 Mar-Apr;34(2):97-102 [434939.001]
  • [Cites] J Pharmacol Exp Ther. 1979 May;209(2):215-8 [438996.001]
  • [Cites] EMBO J. 2001 Aug 15;20(16):4478-89 [11500375.001]
  • [Cites] Science. 2002 Jul 26;297(5581):606-9 [12065746.001]
  • [Cites] Oncogene. 2002 Oct 7;21(45):6884-97 [12362271.001]
  • [Cites] Bioessays. 2003 Jun;25(6):589-95 [12766948.001]
  • [Cites] Cell. 2007 Apr 20;129(2):289-301 [17412408.001]
  • [Cites] Cell Oncol. 2007;29(3):211-8 [17452773.001]
  • [Cites] J Cell Sci. 2007 May 1;120(Pt 9):1572-83 [17405815.001]
  • [Cites] Toxicol In Vitro. 2003 Oct-Dec;17(5-6):587-94 [14599449.001]
  • [Cites] Leukemia. 1999 Nov;13(11):1784-9 [10557053.001]
  • [Cites] Carcinogenesis. 2000 May;21(5):1067-8 [10783335.001]
  • [Cites] J Natl Cancer Inst. 2001 Feb 21;93(4):277-83 [11181774.001]
  • [Cites] Mol Cell. 2001 Feb;7(2):249-62 [11239454.001]
  • [Cites] Nat Med. 2001 Jul;7(7):814-20 [11433346.001]
  • [Cites] Environ Health Perspect. 1990 Apr;85:145-50 [2384059.001]
  • [Cites] Nat Genet. 2005 Sep;37(9):958-63 [16116422.001]
  • [Cites] Nat Genet. 2005 Sep;37(9):934-5 [16116423.001]
  • [Cites] Cancer Cell. 2005 Sep;8(3):255-65 [16153896.001]
  • [Cites] J Clin Oncol. 2006 May 10;24(14):2137-50 [16682732.001]
  • [Cites] Semin Hematol. 2006 Jul;43(3):147-56 [16822457.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1495-501 [16896039.001]
  • [Cites] Cancer Res. 2006 Sep 15;66(18):9017-25 [16982743.001]
  • [Cites] Oncogene. 2006 Sep 25;25(43):5875-84 [16998502.001]
  • [Cites] Mutat Res. 2004 Oct 4;554(1-2):375-85 [15450433.001]
  • (PMID = 18475298.001).
  • [ISSN] 1532-1827
  • [Journal-full-title] British journal of cancer
  • [ISO-abbreviation] Br. J. Cancer
  • [Language] ENG
  • [Grant] United States / NHLBI NIH HHS / HL / T32 HL007781; United States / NHLBI NIH HHS / HL / R01 HL061013; United States / NHLBI NIH HHS / HL / 5P01 HL48546; United States / NHLBI NIH HHS / HL / P01 HL048546; United States / NHLBI NIH HHS / HL / R01-HL61013; United States / NHLBI NIH HHS / HL / R01-HL71795; United States / NHLBI NIH HHS / HL / R01-HL659; United States / NHLBI NIH HHS / HL / R01 HL071795; United States / NCI NIH HHS / CA / P30 CA069533
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / FANCD2 protein, human; 0 / Fanconi Anemia Complementation Group D2 Protein; 0 / Tobacco Smoke Pollution; 63231-63-0 / RNA
  • [Other-IDs] NLM/ PMC2391131
  •  go-up   go-down


96. Rosenbaum DH, Bhojani RA, Dikmen E, Kaiser PA, Paul MC, Wait MA, Meyer DM, Jessen ME, Yancy CW, Rosenblatt RL, Torres F, Perkins S, Ring WS, DiMaio JM: Routine computed tomography screening of the chest in high-risk cardiac transplant recipients may improve survival. J Heart Lung Transplant; 2005 Dec;24(12):2043-7
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Multiple studies have demonstrated an increased incidence of lung cancer in the heart transplant population.
  • We reviewed our cardiac transplantation experience with respect to the development of bronchogenic carcinoma and explored the role of routine chest computed tomography (CT) in its surveillance.
  • METHODS: We performed a review of our cardiac transplantation experience, highlighting the incidence of lung cancer, and we analyzed our recent experience with screening chest CT in lung cancer surveillance in this patient group.
  • RESULTS: Eighteen patients developed 20 cases of bronchogenic carcinoma for an incidence of 6.83%.
  • All patients diagnosed with lung cancer by chest CT underwent surgical resection; however, only 37.5% of patients diagnosed with lung cancer by chest X-ray were found at an appropriate stage for resection (p = 0.025).
  • CONCLUSIONS: Cardiac transplant recipients have a significant risk of developing bronchogenic carcinoma.
  • Routine chest CT screening in high-risk patients may enable clinicians to identify disease earlier, which is essential for the option of surgical resection and, therefore, prolonged survival.
  • [MeSH-major] Carcinoma, Bronchogenic / radiography. Heart Transplantation. Lung Neoplasms / radiography. Postoperative Complications / radiography. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - After Surgery.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - Heart Transplantation.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16364847.001).
  • [ISSN] 1557-3117
  • [Journal-full-title] The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
  • [ISO-abbreviation] J. Heart Lung Transplant.
  • [Language] eng
  • [Grant] United States / NIGMS NIH HHS / GM / 5T32GM08593
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


97. Fontinele e Silva J, Barbosa Mde P, Viegas CL: Small cell carcinoma in Pancoast syndrome. J Bras Pneumol; 2009 Feb;35(2):190-3
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Small cell carcinoma in Pancoast syndrome.
  • The process is typically caused by a neoplasm.
  • The majority of cases of Pancoast syndrome are caused by bronchogenic carcinoma.
  • The most commonly found histologic subtypes are adenocarcinoma and epidermoid carcinoma.
  • There have been very few reports of small cell lung carcinoma in the genesis of Pancoast syndrome.
  • We describe the case of a patient with Pancoast syndrome caused by small cell lung carcinoma and discuss the aspects related to the diagnosis and treatment.
  • [MeSH-major] Carcinoma, Small Cell / pathology. Lung / pathology. Pancoast Syndrome / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19287924.001).
  • [ISSN] 1806-3756
  • [Journal-full-title] Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia
  • [ISO-abbreviation] J Bras Pneumol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


98. Dasgupta A, Bagchi A, Nag S, Bardhan S, Bhattacharyya P: Profile of respiratory problems in patients presenting to a referral pulmonary clinic. Lung India; 2008 Jan;25(1):4-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Obstructive airway diseases (COPD and asthma) were the most common (43%) problem followed by infective lung diseases (15%) including tuberculosis, bronchogenic carcinoma (8%), ILD (4%), haemopty-sis of undiagnosed etiology (4.5%), chronic cough of undiagnosed etiology (6.5%) and pleural diseases (4.6%).
  • Other diseases like obstructive sleep apnoea, sarcoid-osis, systemic diseases with lung involvements etc., and non respiratory problems formed the rest (14.4%).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Respir Crit Care Med. 1998 Aug;158(2):547-54 [9700134.001]
  • [Cites] Indian J Cancer. 1967 Jun;4(2):105-13 [6082631.001]
  • [Cites] Indian J Chest Dis. 1967 Jul;9(3):161-4 [5634279.001]
  • [Cites] Indian J Chest Dis Allied Sci. 2006 Oct-Dec;48(4):243-4 [16970287.001]
  • [Cites] Allergy. 2007 Feb;62(2):102-12 [17298416.001]
  • [Cites] J Indian Med Assoc. 1988 Feb;86(2):28-9 [3397553.001]
  • [Cites] Arch Environ Health. 2001 Jan-Feb;56(1):58-64 [11256858.001]
  • [Cites] Curr Opin Pulm Med. 2007 Jan;13(1):8-12 [17133118.001]
  • [Cites] Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):646-64 [10673212.001]
  • (PMID = 20390068.001).
  • [ISSN] 0974-598X
  • [Journal-full-title] Lung India : official organ of Indian Chest Society
  • [ISO-abbreviation] Lung India
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC2851148
  • [Keywords] NOTNLM ; Asthma / COPD / Cough / Hemoptysis / ILD. / OPD Statistics / Undiagnosed etiology
  •  go-up   go-down


99. Shim HK, Kwon HW, Kim TS, Kim SK: Endotracheal Metastasis Seen on FDG PET/CT in a Patient with Previous Colorectal Cancer. Nucl Med Mol Imaging; 2010 Dec;44(4):294-6

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endotracheal Metastasis Seen on FDG PET/CT in a Patient with Previous Colorectal Cancer.
  • Endotracheal/endobronchial metastasis, which is from either primary bronchogenic carcinoma or a tumor of non-pulmonary origin, is a rare but life-threatening condition.
  • We herein report on a patient with a FDG-avid endotracheal eccentric mass that was confirmed as metastasis from rectal cancer.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 24899967.001).
  • [ISSN] 1869-3474
  • [Journal-full-title] Nuclear medicine and molecular imaging
  • [ISO-abbreviation] Nucl Med Mol Imaging
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Other-IDs] NLM/ PMC4042920
  • [Keywords] NOTNLM ; Colorectal cancer / Endotreacheal metastasis / FDG PET-CT
  •  go-up   go-down


100. Dolezel J, Jedlicka V, Capov I: [Robot-assisted pulmonary lobectomy--our first experiences]. Rozhl Chir; 2008 Mar;87(3):121-3; discussion 124

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Robot-assisted lobectomy is a safe method of pulmonary resection in the early stages of bronchogenic carcinoma (Ia, Ib); it ensures a faster convalescence of the patient compared with open surgery.
  • [MeSH-minor] Aged. Carcinoma, Non-Small-Cell Lung / surgery. Female. Humans. Lung Neoplasms / surgery. Male. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18459437.001).
  • [ISSN] 0035-9351
  • [Journal-full-title] Rozhledy v chirurgii : měsíčník Československé chirurgické společnosti
  • [ISO-abbreviation] Rozhl Chir
  • [Language] cze
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Czech Republic
  •  go-up   go-down






Advertisement